Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2022 Jul 15.
Published in final edited form as: Appl Sci (Basel). 2021 Nov 29;11(23):11301. doi: 10.3390/app112311301

Fe3O4 Nanoparticles: Structures, Synthesis, Magnetic Properties, Surface Functionalization, and Emerging Applications

Minh Dang Nguyen 1, Hung-Vu Tran 1, Shoujun Xu 1, T Randall Lee 1,*
PMCID: PMC9285867  NIHMSID: NIHMS1822494  PMID: 35844268

Abstract

Magnetite (Fe3O4) nanoparticles (NPs) are attractive nanomaterials in the field of material science, chemistry, and physics because of their valuable properties, such as soft ferromagnetism, half-metallicity, and biocompatibility. Various structures of Fe3O4 NPs with different sizes, geometries, and nanoarchitectures have been synthesized, and the related properties have been studied with targets in multiple fields of applications, including biomedical devices, electronic devices, environmental solutions, and energy applications. Tailoring the sizes, geometries, magnetic properties, and functionalities is an important task that determines the performance of Fe3O4 NPs in many applications. Therefore, this review focuses on the crucial aspects of Fe3O4 NPs, including structures, synthesis, magnetic properties, and strategies for functionalization, which jointly determine the application performance of various Fe3O4 NP-based systems. We first summarize the recent advances in the synthesis of magnetite NPs with different sizes, morphologies, and magnetic properties. We also highlight the importance of synthetic factors in controlling the structures and properties of NPs, such as the uniformity of sizes, morphology, surfaces, and magnetic properties. Moreover, emerging applications using Fe3O4 NPs and their functionalized nanostructures are also highlighted with a focus on applications in biomedical technologies, biosensing, environmental remedies for water treatment, and energy storage and conversion devices.

Keywords: Fe3O4 nanoparticles, magnetic properties, core-shell structures, nanocomposites, surface functionalization, biomedical applications, biosensing, environmental applications, energy storage

1. Introduction

Magnetic nanoparticles (MNPs) are an interesting class of nanomaterials that have been extensively explored for use in many technological applications [15]. MNPs have been utilized in sensing technologies, memory storage devices, magnetic separation, magnetic labeling, and catalytic processes [69]. In biomedical applications, MNPs have been used to induce heating for hyperthermia treatments, to provide contrast effects for magnetic imaging, and for the remote control of targeted drug delivery [10,11]. Among magnetic materials, iron oxide NPs are promising nanomaterials due to their great biocompatibility [12,13]. The biocompatibility of iron oxide NPs is the main driving force of substantial research efforts to commercialize these NPs for advanced medical technology applications [14]. Although numerous iron oxides are known, the term “iron oxides” typically refers to three types: Fe3O4 (magnetite), α-Fe2O3 (hematite), and γ-Fe2O3 (maghemite) [15]. Among all iron oxides, Fe3O4 has attracted more attention due to its superior magnetic properties. In the last two decades, research on Fe3O4 NPs has achieved remarkable progress in not only the synthesis of homogeneous core magnetic Fe3O4 NPs but also the preparation of advanced nanoarchitectures (core–shell, composites, functionalized surfaces, etc.) and the application of these nanomaterials in various fields [1619]. According to the Web of Science, more than 41,000 research papers with the keyword “Fe3O4” have been published in the last 20 years, as shown in Figure 1. In the last 10 years, the number of these publications has increased drastically, with several hundred papers published per year. These numbers reflect the great attention given to Fe3O4 nanomaterials by the research community in both fundamental studies and applied science.

Figure 1.

Figure 1.

Numbers of articles with the keyword “Fe3O4” published in the last 20 years. Data originated from the Web of Science. (Data from 2021 were collected until September 2021).

Fe3O4 has attracted more attention than other iron oxides or ferrite spinel oxides (MFe2O4 with M = Co, Ni, Mg, etc.) because of its superior magnetic properties, electronic conductivity, and biocompatibility. The magnetic properties of Fe3O4 can be explained by its crystal structure. Magnetite has a cubic inverse spinel crystal structure consisting of Fe2+ cations occupying 25% of the octahedral interstitial sites and Fe3+ cations occupying 25% of the octahedral sites and 12.5% of the tetrahedral sites, and thirty-two O2− anions in its unit cell [20,21]. The magnetic moments of Fe3+ and Fe2+ cations in octahedral holes are coupled ferromagnetically. However, the Fe3+ ions in tetrahedral sites possess magnetic dipoles in the reverse direction of the Fe3+ ions in the octahedral sites. Therefore, Fe3O4 is a ferrimagnetic material with high saturation magnetization (MS) and low coercivity (HC) due to the antiferromagnetically coupled Fe3+ cations in tetrahedral and octahedral sites of its crystal structure. Sometimes, the term ferromagnetic properties or ferromagnetism is also used for Fe3O4, which indicates that it exhibits magnetic properties in the absence of a magnetic field. Regarding other iron oxide phases, maghemite is also a ferrimagnetic material, and hematite is considered a weak ferromagnetic material. The maximum values of saturation magnetization (MS) for magnetite (Fe3O4) and maghemite (γ-Fe2O3) are 98 emu/g and 82 emu/g, respectively [10], whereas the values for saturation magnetization of hematite (α-Fe2O3) are usually modest and reported to be approximately 2 to 4 emu/g [2224]. In the case of spinel ferrite MFe2O4, the maximum saturation magnetization values for CoFe2O4, NiFe2O4, and MgFe2O4 are 94 emu/g, 56 emu/g, and 31 emu/g, respectively [10]. Regarding biocompatibility, Fe3O4 and γ-Fe2O3 have been used in various formulations approved by the USA Food and Drug Administration (FDA) as a therapy for iron deficiency and as contrast agents for magnetic resonance imaging [14,25,26]. Magnetite (Fe3O4) also exhibits better electronic conductivity than other magnetic oxides in the same category due to its half-metallic nature with room temperature conductivity σ = 200 (Ω·cm)−1 [27,28]. In contrast, maghemite and hematite are semiconductors with bandgaps of approximately 2.0 eV, which are certainly less conductive than half-metallic materials [15,29]. Other spinel ferrites MFe2O4 are also mostly semiconductors [30,31]. In addition, Fe3O4 possesses the first-order transition of the Verwey transition (metal–insulator transition) at approximately 115–124 K, while this property is absent in maghemite [19,32]. Due to the Verwey transition properties, Fe3O4 is potentially very useful in various physical device applications. Other advantageous properties of Fe3O4 are its high electrochemical activity and high theoretical capacity, which are important for energy storage device applications [33]. In addition to these main properties, the natural abundance, inexpensiveness, and ecofriendliness are additional advantages that allow large-scale applications of Fe3O4-based NPs.

Numerous efforts to summarize progress in the synthesis, functionalization, nanoarchitectures, and applications of Fe3O4-based NPs have been reported. Several reviews have highlighted the use of iron oxide NPs (magnetite and maghemite) in biomedical applications [3436]. The bioinspired synthesis and green biosynthesis of magnetite NPs have been summarized by Mirabello et al. [37] and Yew et al. [38]. Although the growth mechanism of Fe3O4 nanostructures and their applications were reviewed by Hou and coworkers in 2011 [17], numerous advances in the field have been achieved in the last 10 years. Other reviews have focused on special physical properties or effects, such as the Verwey transition [19] and exchange bias effects [16], which provide opportunities to integrate Fe3O4 NPs in electronic devices and physical instruments. Recently, Siregar et al. highlighted the use of Fe3O4 nanostructures in pollutant gas sensor systems [39], and Liu et al. reviewed synthetic methods and applications of Fe3O4 in multiple fields [18]. Despite the numerous available reviews, a comprehensive review focusing on the relationship of sizes and shapes (geometries) with the magnetic properties of Fe3O4 NPs, synthetic methods targeting each specific size and shape of Fe3O4 NPs, and preparations of appropriate nanoparticle systems for targeted applications is still needed [4044]. We envision that the size-property and geometry-property relationships are very important factors contributing to the performance of Fe3O4 NPs in most applications. Therefore, this review will focus on the following problems:

  1. Synthetic methods to control the structures of Fe3O4 NPs with a focus on the sizes and geometries;

  2. Size- and geometry-to-magnetic property relationships of Fe3O4 NPs;

  3. Effects of size, geometries, and properties of NPs on target applications;

  4. Roles of functionalization and nanoarchitectures of Fe3O4 NPs in target applications.

We elucidate the solutions to these problems by first summarizing synthetic methods to obtain different nanostructures of Fe3O4 and their magnetic properties. In particular, the syntheses of various sizes of spherical, cubic, nanorod, 2D nanoplate (hexagonal and triangular shapes), hollow, and multipod nanocrystal Fe3O4 NPs are summarized together with their magnetic properties, including saturation magnetization and coercivity. In this section, synthetic strategies to tailor the size and morphology of NPs are mainly discussed. Next, we discuss the need to combine various characterization techniques to study Fe3O4 NPs. Then, we will highlight the use of Fe3O4-based NPs in emerging applications, such as biomedical applications (hyperthermia, MRI contrast agents, and drug delivery), biosensing, environmental applications for the removal of heavy metals and organic pollutants, and applications in energy storage devices. In this section, we will focus on the effects of the sizes, geometries, and thus magnetic properties of NPs, as well as the important roles of functionalization in enhancing the performance of Fe3O4 NPs in these applications. Figure 2 illustrates the scope of this review.

Figure 2.

Figure 2.

Fe3O4 NPs with various nanostructures and sizes used in emerging biomedical, biosensing, environmental, and energy applications.

2. Structures, Synthesis, and Magnetic Properties of Fe3O4 Nanoparticles

Fe3O4 NPs exhibit either superparamagnetic (SPM) or ferrimagnetic (FM) behavior. Figure 3a shows examples of magnetization curves of the SPM curve (green) and FM hysteresis loop (orange color) of magnetic NPs represented by the magnetization value (emu/g) versus the applied magnetic field (Oe). In the presence of an external magnetic field, the magnetic material is magnetized and reaches a saturated value of magnetization called “saturation magnetization” (MS), which is the highest value of magnetization that the material can achieve. In addition to MS, the hysteresis curve of FM materials also exhibits coercivity (HC) and remnant magnetization (MR) values, which indicate how difficult the materials are to demagnetize and how much magnetization is retained in the absence of an applied magnetic field, respectively. For SPM NPs, HC and MR are equal to zero. Consequently, SPM materials do not exhibit magnetic properties without an applied magnetic field; however, they respond magnetically in the presence of an external magnetic field. SPM NPs have several advantages, such as preventing the agglomeration of NPs (caused by magnetic attraction) and a sensitive response to a remote-controlled magnetic field. In contrast, FM materials exhibit a certain magnetization value in the absence of an external magnetic field. Therefore, FM NPs always retain strong magnetic properties, which are potentially useful for applications that always require the existence of strong magnetic properties/signals.

Figure 3.

Figure 3.

(a) Magnetization versus applied field (M–H) curves for superparamagnetic (SPM) (green color) and ferrimagnetic (FM) (orange) Fe3O4 nanoparticles and (b) relations between size, coercivity, and magnetic behavior.

At the nanoscale, Fe3O4 nanoparticles have different magnetic properties that are influenced by their structures, including size, morphology, crystallinity, and surface properties [2,42,45,46]. These parameters are strongly affected by the synthetic methods and chemicals used in their syntheses, such as iron precursors, surfactants, reducing agents, and solvents. Thus, the appropriate selection of a method to synthesize Fe3O4 NPs is very important to ensure the success of their applications. In the scope of this review, we focus on analyzing the magnetic features of Fe3O4 NPs at room temperature (RT) due to the special interest in their use in various technologies and applications. The superparamagnetic (SPM) and ferrimagnetic (FM) behaviors of Fe3O4 NPs depend on size, shape, crystallinity, and surface properties and are even affected by synthetic methods [4650]. Figure 3b illustrates the relationship of the Fe3O4 NP size (diameter) with its magnetic behavior and coercivity. Two important size–magnetic property transitions of Fe3O4 NPs are superparamagnetic size (rSP) and single-domain size (rSD), which usually exist in NPs with diameters of ~25 nm and ~80 nm, respectively [45,51]. Superparamagnetic size (rSP) is the point at which the magnetic property of NPs transitions from the superparamagnetic to the ferromagnetic state, as NPs with a size larger than rSP have a coercivity larger than 0 (HC > 0). The features of the superparamagnetic behavior of NPs are coercivity and remnant magnetization equal to zero (HC = 0 and MR = 0) at temperatures above their blocking temperature (TB). In particular, NPs exhibit superparamagnetic behaviors at temperatures above TB (T > TB) and ferromagnetic behavior at temperatures below TB (T < TB). When the size of particles is adequately small (r < rSP), thermal energy overcomes anisotropy energy at the blocking temperature (TB), and nanoparticles become superparamagnetic. In our context, superparamagnetic NPs (at RT) should exhibit a blocking temperature much lower than room temperature. The single-domain size (rSD) is the size at which NPs spontaneously separate into multiple domains, causing a decrease in coercivity when the size of NPs increases. However, size is not a conclusive parameter that dictates the magnetic properties. Depending on the size, geometry, crystallinity, surface properties, and synthetic methods, the superparamagnetic–ferrimagnetic transition in Fe3O4 has been identified at approximately 20 nm [52], or even at ~30 nm [53]. Similar to the superparamagnetic–ferrimagnetic transition, the single-domain to multidomain transition occurs at different values and depends on the overall size, degree of crystallinity, and surface properties of NPs. Thus, the relationship between the size and magnetic properties of Fe3O4 NPs is not easy to predict due to various contributing factors.

In general, the magnetic properties of Fe3O4 NPs such as saturation magnetization (MS) and coercivity (HC) are strongly affected by four main factors including finite size effects, surface effects, magnetic anisotropy, and the degree of crystallinity [2,5,42,45,46]. These factors are correlated to each other and strongly influenced by the size and geometry of the NPs. The finite size effects are typically related to special behaviors of a substance in a finite nanoscale size, such as quantum confinement of electrons [2]. In nano-magnetism, the single-domain limit and the superparamagnetic limit (presented in Figure 3) are the most studied finite size effects, which typically dictate the magnetic behavior of particles for ferrimagnetic and superparamagnetic responses, respectively [2]. While the superparamagnetic limit has been discussed in the previous paragraph, the single-domain limit is driven by balancing magnetostatic energy and domain wall energy, which induces the formation of magnetic domains [2]. Thus, the finite size effect of the single-domain limit regulates the change in ferrimagnetic properties, such as the change in coercivity in ferrimagnetic NPs when the size of the NPs increases. As illustrated in Figure 3b, increasing the size of NPs boosts HC until the specific size limit called the “single-domain limitation” is reached, where the separation of multiple domains begins and induces the decrease in HC.

The surface effect has been used to rationalize the decrease in MS of smaller Fe3O4 NPs due to a surface-disordered spin layer [45]. For small NPs, the ratio of surface atoms to bulk atoms increases, giving rise to more significant contributions of surface spins to magnetization. The detrimental role of the surface effect on magnetization can be rationalized by various contributions, such as canted spins, magnetically dead layers, and spin glass-like behavior of surface spins [2]. As a consequence, the surfactants coated on the NPs also alter the magnetic properties of NPs, which can either positively or negatively affect the surface spin. Thus, the size of NPs can help to predict the change in MS; however, it is not the conclusive factor. In addition, as different geometries of NPs have different ratios of surface atoms, Fe3O4 NPs with comparable sizes but having different shapes can exhibit different magnetic properties. Magnetic anisotropy describes the directional dependence of the magnetic moment in materials. Magnetic anisotropy is a crucial factor contributing to the effect of the size and geometry on magnetic properties. In this context, magnetic anisotropy is related to magnetocrystalline anisotropy and shape anisotropy, which correspond to the preferential magnetization direction of the crystals and the departure from sphericity of particle shapes, respectively [2]. The magnetic anisotropy of nanoparticles can be higher than the value obtained from the crystalline and shape anisotropy due to enhanced surface anisotropy [2]. Furthermore, shape anisotropy is also a vital factor to determine the strength of the magnetic properties of magnetic NPs [2,5]. Finally, highly crystalline structures can significantly enhance the magnetic properties of NPs, even NPs with comparable sizes and shapes [46,47]. Enhanced crystallinity was also proposed as the reason for increasing the magnetic properties of cubic versus spherical Fe3O4 NPs [42]. These contributing factors, driven by the size and geometries of Fe3O4 NPs, underpin the fundamental phenomena that rationalize or predict the magnetic properties when the size and geometries of Fe3O4 NPs are varied.

Due to the strong effects of the geometry and size on the properties of NPs, we will summarize the advances in the synthesis of Fe3O4 NPs with different geometries and sizes. For a particular geometry, we will cover the synthesis routes for different size ranges and compare the important properties (e.g., saturated magnetization MS and coercivity HC) of these NPs. We focus on three geometries, spherical, cubic, and rod, and highlight recent advances in the synthesis of other sophisticated geometries, such as 2D hexagonal/triangular shapes, multiarmed structures, octahedrons, and hollow structures. We focus on methods with high efficiency, good control of geometry uniformity, narrow size distributions, and the ability to tune the size of particles.

2.1. Fe3O4 Spherical Nanoparticles (SNPs)

In this section, Fe3O4 spherical nanoparticles (SNPs) will be categorized into two size ranges based on their structures, crystallinity, and magnetic behaviors. The first type is Fe3O4 SNPs with a size smaller than 25 nm and a single-crystalline structure that probably exhibits superparamagnetic behavior at room temperature. This type of SNP is widely applied in hyperthermia, as a contrast agent in magnetic resonance imaging, and in drug delivery. Table 1 summarizes the available synthetic methods and the strategy for controlling the size to obtain single-crystalline Fe3O4 SNPs with a size less than 25 nm, as well as the magnetic properties of saturation magnetization at room temperature for comparisons of these SNPs. The second type of SNP is usually polycrystalline NPs with diameters generally larger than 25 nm to even hundreds of nanometers. The structure of these Fe3O4 SNPs is often characterized by the stacking or agglomeration of small primary nanocrystals to form larger SNPs as the secondary structure. In this size range, the magnetic properties of SNPs at room temperature are either ferrimagnetic or superparamagnetic, depending on the crystallite size, the overall size of NPs, and the interaction of nanosized subunits. Together with summarizing the available synthetic methods of Fe3O4 SNPs with sizes ranging from 25 nm to a few hundred nanometers, Table 2 also provides detailed information on the particle size, crystallite size, and magnetic properties, including MS and HC, at room temperature.

Table 1.

Syntheses and magnetic properties of spherical Fe3O4 NPs with a size <25 nm in a superparamagnetic regime at room temperature.

Diameter (nm) Precursor Method Size Control Factor MS (emu/g)a Ref.
4 (seeds), 8, 12, 16 Fe(acac)3 Thermal decomposition Seed-mediated growth 82 (for 16 nm) [54]
6 (seeds), 8, 10, 16 Fe(acac)3 Thermal decomposition Temperature, seed-mediated growth 83 (for 16 nm) [55]
5, 9, 12, 16, 22 Fe(oleate)3 Thermal decomposition Different organic solvents or concentration of surfactant Unknown [56]
7, 8, 9, 10 Fe(acac)3 Thermal decomposition Ratio OAm/solvent. (OAm: surfactant and reducing agent) 76, 77, 79, 80 [57]
8, 11, 15, 18 Fe(acac)3 Thermal decomposition Amount of surfactant ≈65–75 [58]
8, 11 Fe(acac)3 Solvothermal Different surfactants 73.1, 109.4 (emu/g Fe) [59]
4, 12
60
FeCl3·6H2O Solvothermal Reaction time 3, 59
84 (ferri)
[60]
15.4, 16.7, 22.4, 31.1 FeCl3·4H2O Hydrothermal Concentration of reactants and solvent composition 53.3, 65.1, 81.2, 97.4 [61]
4.2, 7.4, 8.1, 17, 45 Fe(acac)3 Thermal decomposition Reducing agent, surfactant 75, 70, 65, 82, 92 [62]
6.6, 11.6, 17.8 FeCl2·4H2O
FeCl3·6H2O
Solvothermal Solvent composition 71, 77, 83 [63]
11 FeCl2·4H2O
FeCl3·6H2O
Sonochemistry None 80 [64]
a

Saturation magnetization (MS) value at 300 K. Bold indicates that the size of NPs (diameter) exceeds 25 nm.

Table 2.

Syntheses and magnetic properties of SNPs with sizes larger than 25 nm.

Diameter (nm) Precursor and Reagents Solvent Size Control Factor Grain Size (nm) MS (emu/g) HC (Oe) [Ref.]
200, 400, 800 FeCl3·6H2O, NaAc, PEG Ethylene glycol (EG) Rxn time UN 81.9
UN, UN
UN [48]
31, 53, 71, 93, 141, 174 FeCl3, NaOH, PAA Diethylene glycol (DEG) NaOH stock solution ≈10 UN, 30.9, UN, 56.7, UN, 63.5 SPM [53]
120, 190, 560 (SPs) Fe3O4 NPs functionalized with OA and DTAB in chloroform. PVP in EG. Concentration of DTAB and nanoparticles 5.8 (NPs) UN SPM [67]
[68]
280 FeCl3.6H2O Na(acrylate) NaAc EG - 5.9, 6.9, 8.3, 13.5 36.2, 38.7, 46.5, 67.2 SPM [46]
6, 60, 120, 170 EG/DEG Solvent composition 10 UN SPM
20, 90, 165, 300. FeCl3·6H2O, NaAc, PVP EG/DEG Solvent composition 10–20 62.1, 62.1, 62.8, 63.9 8, 20, 28, 16 [47]
82, 139, 188, 544, 728, 1116 FeCl3·6H2O, NaAc, PAA, H2O EG H2O 15.4, 20.7, 23.9, 18.6, 17.7, 17.6 56, 71, 73, 79, 80, 80.27 115, 141, 149, 139, 136, 127 [70]
100, 135, 150, 175, 275 FeCl3·6H2O, NaAc, PVP EG Rxn time 17, 17, 15, 12, 11 69, 72, 65, 32, 56 106, 42, 66, 21, 28 [42]
120, 440, 700 FeCl3·6H2O, NaAc, PEG EG, DEG Solvent composition, FeCl3 18, 17, 17 78, 84, 87 62, 73, 72 [43]

UN denotes unknown, as the information was not provided in the literature. SPM denotes superparamagnetic, HC = MR = 0 (at RT). Values in italics indicate that the data were estimated from figures provided in the referenced articles.

Thermal decomposition of iron complexes at high temperature in high-boiling point organic solvents has proven to be an effective method to generate Fe3O4 nanospheres with sizes ranging from 4 to 30 nm [5458]. Sun et al. reported the thermal decomposition of Fe(acac)3 in phenyl ether (boiling point: 260 °C) at 265 °C to synthesize monodisperse 4 nm Fe3O4 SNPs [54]. 1,2-Hexadecanediol was used as the reducing agent, and a mixture of oleic acid (OA) and oleylamine (OAm) was utilized as the surfactant. The as-synthesized 4 nm NPs were then used as seeds for seed-mediated growth to obtain 8, 16, and 20 nm SNPs with the assistance of stearyl alcohol. Larger seeds with an average diameter of 6 nm were prepared by refluxing at a higher temperature of 300 °C in the higher-boiling point benzyl ether solvent (boiling point: 296 °C) [55]. In this method, 1,2-hydrocarbon diols served as excellent reducing agents for the synthesis of high-quality Fe3O4 SNPs with good yields for use as seed NPs. Interestingly, the seed-mediated growth processes normally require long-chain mono-alcohols to grow larger particles rather than diol derivatives. Later, Xu et al. [57] reported a more convenient one-pot method to synthesize Fe3O4 nanospheres with sizes of 7, 8, 9, and 10 nm by simply controlling the ratio of OAm and benzyl ether, as shown in Figure 4a. Here, oleylamine served as a multifunctional reagent: a strong reductive agent and an effective capping agent [57,65]. The obtained NPs exhibited a homogeneous size and uniform spherical morphology, as verified using transmission electron microscopy (TEM). Selected TEM images of Fe3O4 SNPs with sizes of 7 and 10 nm are presented in Figure 4b,c, respectively. The heating procedure is very important in the thermal decomposition of Fe(acac)3, which usually requires maintenance at 200 °C for nucleation prior to refluxing or a quick ramping rate of 20 °C/min. Therefore, precisely controlling the temperature of the reaction and a powerful heating process represent a technical challenge for large-scale production. Later, Lee and coworkers successfully lowered the reflux temperature to 200 °C using alkaline metal reagents to assist with the reduction of iron precursors [58]. In the presence of Mg(acetate)2, monodisperse Fe3O4 SNPs with sizes of 8, 11, 15, and 18 nm were prepared. Park et al. reported an ultralarge-scale synthesis with 40 g of products obtained per single reaction using the inexpensive and environmentally friendly starting material iron(III) chloride [56]. Nanospheres with sizes of 5, 9, 12, 16, and 22 nm were prepared with a uniform size (size variation < 4.1%) and homogeneous morphology. Iron(III) oleate complexes were first prepared from iron(III) chlorides and sodium oleate before refluxing with oleic acid at 320 °C in different high-boiling point organic solvents to obtain SNPs of different sizes. In addition to the advantages of highly uniform size and morphology, NPs prepared using thermal decomposition usually have hydrophobic surfaces that require surface modifications for applications requiring water-soluble nanosubstances, such as biomedical applications or catalysis in aqueous media. Li and coworkers approached this problem by applying surfactant-free thermal decomposition of the inexpensive precursor FeCl3·6H2O in a strongly polar 2-pyrrolidone solvent [60]. This recipe allowed obtaining SNPs in a wider range of sizes from 4 to 60 nm by simply controlling the reaction time. Thus, thermal decomposition is a useful synthesis method producing high-quality Fe3O4 SNPs with good uniformity in size and morphology.

Figure 4.

Figure 4.

(a) Schematic synthesis of Fe3O4 NPs with sizes of 7, 8, 9, and 10 nm. Selected TEM images of Fe3O4 NPs with sizes of (b) 7 ± 0.5 nm and (c) 10 ± 0.8 nm. Scale bar 20 nm. Reproduced with permission from ref. [57]. Copyright 2009 American Chemical Society. (d) TEM image of spherical Fe3O4 NPs with a size of 200 nm. Reproduced with permission from ref. [48]. Copyright 2005 John Wiley and Sons.

In addition to thermal decomposition, solvothermal methods are also used to synthesize spherical superparamagnetic NPs in this size range below 25 nm at lower temperatures than thermal decomposition methods. Caruntu et al. prepared Fe3O4 SNPs with sizes ranging from 6.6 to 17.8 nm through the solvothermal mixing of FeCl2 and FeCl3 precursors in solvent mixtures using different ratios of diethylene glycol and N-methyl diethanolamine [63]. Fe(acac)3 has also been used as a precursor in the solvothermal synthesis of 8 and 11 nm SNPs by employing different surfactants [59]. In addition, direct preparation of SNPs with hydrophilic surfaces has also been developed [18,66]. However, the size distribution and uniformity of the spherical geometry are not as good as SNPs prepared using thermal decomposition at high temperatures. For example, Ge and coworkers synthesized 15 to 31 nm NPs by oxidizing FeCl2·4H2O in a basic aqueous solution [61]. These NPs exhibit the gradual transition from ferromagnetic to superparamagnetic when decreasing in size. Kim and colleagues developed a facile route for the large-scale sonochemical synthesis of 11 nm Fe3O4 SNPs with MS = 80 emu/g using inexpensive and nontoxic reactants, such as FeCl2, FeCl3, and H2O [64]. Thus, among the various synthesis methods, thermal decomposition is the most effective for the synthesis of Fe3O4 nanospheres with a size less than 25 nm. The size and uniformity of NPs can be effectively controlled in this method by modifying the amounts of surfactants, heating protocol, reducing agents, or solvent compositions. The main drawback of this method is the technical requirements for maintaining high temperatures and fast heating rates.

Spherical particles in the size range from 25 to even a few hundred nanometers have been synthesized successfully using various recipes and solvothermal methods [42,43,48]. In this size range, spherical Fe3O4 NPs exhibit diverse magnetic behaviors, either superparamagnetic or ferrimagnetic (Table 2). In contrast to single-crystalline SNPs with sizes below 25 nm, magnetite particles in the larger size range (diameter > 25 nm) are usually polycrystalline NPs. These NPs are composed of numerous primary nanocrystals aggregated to form secondary structure NPs. Consequently, the magnetic properties of these nanospheres depend on the size of the nanosized subunits, the overall size of the nanospheres, interactions of the primary crystals, surface properties, and morphology. These NPs are either ferrimagnetic or superparamagnetic, depending on both their overall size and the size of the subunits. These types of nanoparticles are also called “colloidal nanocrystal clusters” (CNCs) [53] or colloidal superparticles (SPs) [67,68]. For example, Zhuang and coworkers prepared iron oxide NPs with a size of 5.8 nm through the thermal decomposition of iron(III) oleate [56] and then used nanoparticle micelle formation to form larger supercrystalline colloidal SPs with sizes of 120, 190, and 560 nm via solvophobic interactions [67,68]. These colloidal SPs have superparamagnetic properties at room temperature along with excellent stability in polar solvents. Deng et al. reported single-crystalline, monodisperse ferrite NPs with tunable sizes ranging from 200 to 800 nm using a solvothermal reduction method [48]. A TEM image of the obtained mean 200 nm spherical Fe3O4 NPs is shown in Figure 4d. Later, this method was widely applied to synthesize SNPs for various applications, including protein detection [43] and drug delivery [69]. In the presence of a polyethylene glycol (PEG) surfactant, FeCl3·6H2O was reduced in ethylene glycol at 200 °C assisted by sodium acetate, an electrostatic stabilizer and a reductive-mediated agent. The size of NPs is simply controlled by the reaction time in the range of 8 to 72 h. Lee and colleagues modified this recipe by adding different surfactants, polyvinylpyrrolidone, refluxing at 180 °C, and manipulating the reaction time from 4 to 24 h to generate NPs with diameters ranging from 100 to 275 nm [42]. Separately, Yin and coworkers successfully synthesized highly water-dispersible Fe3O4 SNPs with sizes from 30 to 180 nm by controlling the hydrolysis of FeCl3 during high-temperature reduction in diethylene glycol [53]. In this recipe, poly(acrylic acid) (PAA) was used as the surfactant and dictated the release of water for hydrolysis upon the addition of NaOH. Thus, the size of NPs can be tuned by adding different amounts of NaOH stock solution in DEG. The packing of small primary crystals with a size of approximately 10 nm to form colloidal nanocrystal clusters (mean size 30–180 nm) has many advantages, such as maintaining superparamagnetic behavior and water-dispersible properties, as well as enhancing the overall magnetization of the nanoparticles. In addition to synthesizing different sizes of secondary structure SNPs with similar crystalline subunits, the preparation of NPs of similar sizes with a tunable degree of crystallinity was reported by Xuan and coworkers. They developed a method to prepare secondary structures of CNCs with a diameter of 280 nm that have tunable crystallite sizes ranging from 5.9 to 21.5 nm [46]. By employing different ratios of sodium acetate and sodium acrylate, grain sizes were controlled without changing the overall size of NPs. Consequently, similar sizes of NPs with different magnetization values were obtained. Moreover, a novel strategy to tune the size of secondary structural Fe3O4 SNPs from 6 to 170 nm was introduced that used different solvent mixture compositions of EG and DEG. Due to its bulky molecules, DEG slowed the aggregation of primary crystals and created more seeds for growing NPs, causing smaller NPs to form [43,46,47]. Utilizing this binary solvent system, the size of spherical NPs was even manipulated in a wider range from 20 to 300 nm [47]. These NPs have either superparamagnetic or ferrimagnetic properties that are dictated by varying the water concentration in the synthesis reaction. Liu et al. studied the effect of the water volume fraction on the crystallite sizes and sizes of NPs in solvothermal synthesis using ethylene glycol as the solvent [70]. They found that the overall size of particles exhibited an extremely wide range (82 to 1118 nm) when the volume percentage of added water increased (from 5.5% to 20.5%). The crystallite size of NPs changes with an increasing water volume ratio and follows an inverse U-shaped curve, with the peak located at a 14.5% water volume ratio. In another study, Chen et al. used a solvent mixture composed of a 1/3 ratio of EG/DEG to obtain 100 nm Fe3O4 NPs and only an EG solvent with a higher concentration of iron precursors to prepare magnetite NPs with sizes of 440 and 720 nm [43]. These NPs were prepared in a pressure vessel at 188 °C under continuous vigorous agitation. Based on these results, which are summarized in Table 2, the solvothermal reduction of the FeCl3 precursor and the controlled hydrolysis of iron cations are useful methods to prepare Fe3O4 in a wide range of sizes, from a few tenths to a few hundred nm. These Fe3O4 NPs have tunable degrees of crystallinity and exhibit different magnetic properties, ranging from superparamagnetic to ferromagnetic. With featured properties and size characteristics, these spherical Fe3O4 nanoparticles can be used in multiple applications, such as sensing, biomedical applications, environmental remedies, and catalysis.

2.2. Fe3O4 Cubic Nanoparticles (CNPs)

Fe3O4 cubic nanoparticles (CNPs) exhibit either superparamagnetic or ferromagnetic behaviors at room temperature, depending on the size of the NPs and the synthetic methods. However, the preparation of cubic magnetite nanocrystals seems to be more challenging than the preparation of spherical NPs. With the nature of a cubic crystal structure, Fe3O4 tends to undergo isotropic growth that easily results in spherical particles. Several studies demonstrated that CNPs possess better crystallinity and stronger magnetic properties than their spherical counterparts with equivalent sizes [41,42,71]. Due to the challenge of maintaining dominant growth along <111> surfaces, only a limited number of synthetic methods are available for the preparation of CNPs with sizes ranging from approximately 10 to 180 nm [49,50,72]. The available synthetic methods, size control factors, and magnetic properties of the corresponding Fe3O4 CNPs are summarized in Table 3.

Table 3.

Syntheses of Fe3O4 nanocubes and their magnetic properties.

Edge (nm) Precursor and Reagents Solvent(s) Size Control Factor MS (emu/g) HC (Oe) Ref.
9.3, 13.4, 15.5, 22.1 Fe(oleate)3
Sodium oleate
Octadecene, diphenyl ether, n-tetracosane Surfactant, Temperature UN SPM [73]
6.5
15
30
Fe(acac)3
1,2-hexadecandiol
Oleic acid, Oleylamine
Benzyl ether Heat rate, Reaction time 39.5
80.5
83.0
SPM
SPM
100 Oe
[49]
22
79
160
Fe(acac)3
Oleic acid
Benzyl ether Concentration, Reaction time, Ligand 152
136
144
emu/g(Fe)
17
88
115
[50]
13
45
67
100
124
180
Fe(acac)3
Decanoic acid
Benzyl ether Ramping rate 54.7
89.9
89.0
92.8
86.0
81.9
SPM
50
UN
UN
UN
50
[72]
12
19
25
38
Fe(acac)3
Decanoic acid
Benzyl ether Degas temperature, Ramping rate UN
80
UN
UN
UN
UN
UN
UN
[52]
14, 19, 24, 35 Fe(acac)3
Decanoic acid
Benzyl ether
Squalene
Ramping rate, Solvent composition 64, 73, 75, 88 26, 28, 7, 23 [44]
22, 36, 57 Fe(acac)3
Mg(acetate)2
Sodium oleate
Oleic acid
Benzyl ether Sodium oleate UN UN [58]
78, 87, 101, 130 Fe(acac)3
Oleic acid
Benzyl ether Concentration, Reaction time 90, 95, 95, 80 139, 165, 177, 80 [42]
10–80 Fe(acac)3
Oleic acid
Sodium oleate
Benzyl ether
1-octadene
1-tetradecene
Concentration, Degassing temperature, Ramping rate 84
(for 15.3 nm)
SPM
(for 15.3 nm)
[74]
80 FeSO4·7H2O
NaOH
H2O None 85.8 emu/g UN [75]
26 Fe(acac)3
Trimethylamine N-oxide
Mercaptoethanol
β-amyrin
Benzyl ether None 51.8 262 [71]

UN denotes unknown, as the information was not provided in the literature. SPM denotes superparamagnetic, HC = MR = 0. MS and HC at 300 K. Values in italics indicate that these data were estimated from figures provided in the references.

Kovalenko and coworkers performed the thermal decomposition of iron(III) oleate in the presence of a sodium oleate surfactant to prepare superparamagnetic cubic Fe3O4 with edge dimensions of 9.3, 13.4, 15.5, and 22.1 nm [73]. Similarly, Yang et al. utilized Fe(acac)3 as a precursor together with 1,2-hexadecandiol, oleic acid, and oleylamine at a high temperature (290 °C) [49]. By increasing the heating rate from 5 to 35 °C/min and shortening the reaction time from 3 h to 20 min, monodisperse nanocubes with controllable sizes ranging from 6.5 to 30 nm were prepared. Hyeon and colleagues reported a simple route using only two reagents, Fe(acac)3 (precursors) and oleic acid (surfactant) [50]. This mixture with a precise 1:2 molar ratio of Fe(acac)3 and oleic acid was degassed and then refluxed at 290 °C in benzyl ether with a fast ramping rate of 20 °C/min. By controlling the concentration of reagents and reaction time, Fe3O4 nanocubes with edge lengths of 79 and 160 nm were obtained. Surprisingly, 1.6 g of magnetite nanocubes with an edge length of 49 nm can be synthesized by scaling up the recipe for the 79 nm nanocubes 10 times. Biphenylcarboxylic acid can be introduced in combination with oleic acid to direct the growth of 22 nm Fe3O4 nanocubes as a method to reduce the nanocube size. Lee and colleagues applied this synthetic approach to prepare Fe3O4 nanocubes with sizes ranging from 78 to 130 nm and explored their biosensing potential [42]. The authors also observed significantly higher magnetic properties of the Fe3O4 nanocubes compared to the nanospheres with a similar volume or comparable diameter/body diagonal dimensions. Using a different fatty acid in the thermal decomposition of Fe(acac)3, Guardia et al. remarkably controlled the sizes of magnetite cubic particles in a broad range from 13 to 180 nm by adjusting the heating rate [72]. Specifically, the mixture of decanoic acid and iron(III) acetylacetonate with a 4-to-1 molar ratio was first heated to 60 °C for degassing, subsequently ramped to 200 °C, and finally refluxed at 290 °C with a slow ramping rate from 0.8 to 5.2 °C/min. Pellegrino and colleagues applied this recipe with modifications to synthesize iron oxide nanocubes with sizes ranging from 12 to 38 nm and investigated their performance in cancer hyperthermia treatments [52]. In addition, solvent mixtures of squalene and benzyl ether were used to overcome the unstable temperature problem of a pure benzyl ether solvent during the reaction [44]. This binary solvent system allowed more precise control of the reaction temperature and improved reproducibility.

Lee and collaborators reported the synthesis of magnetite nanocubes with sizes of 22, 36, and 57 nm at a lower refluxing temperature (200 °C) using an alkaline metal acetate to assist with the reduction process [58]. The amount of sodium oleate surfactant was found to play an important role in controlling the size of nanocubes. Recently, significant progress in understanding the mechanism and size-controllable synthesis was reported by Muro-Cruces, Roca, and coworkers. They used a binary surfactant system containing oleic acid and sodium oleate in mixtures of three solvents (1-octadecene, dibenzyl ether, and 1-tetradecene) to obtain nanocubes with uniform sizes ranging from 9 to 80 nm [74]. Benzyl ether was again identified as a good solvent for the dispersion of Fe(acac)3 precursors; however, it is not stable at high temperatures, producing volatile products such as benzyl aldehyde or benzyl benzoate [44,76]. Thus, the combination of 1-octadecene, dibenzyl ether, and 1-tetradecene was utilized to compromise between the good dispersion of precursors and maintain a stable temperature during synthesis. Figure 5a presents the synthetic strategy using a combination of three solvents and two surfactants to synthesize Fe3O4 nanocubes in a 9–80 nm size range. The growth mechanism is proposed in Figure 5b, starting from the nucleus to the truncated octahedron, then the tetradecahedron, and finally the nanocubes. In this figure, the chemical potentials of crystal facets are presented from low to high, as indicated by a green-to-red color scale. In addition to thermal decomposition, magnetite nanocubes have also been synthesized using sonochemistry [75,77], precipitation [78], and solvothermal green synthesis [71]. However, thermal decomposition at high temperatures assisted by fatty acid ligands is the most efficient method that provides uniform cubic geometries, a narrow size distribution, and tunable sizes in a wide range from approximately 10 to 180 nm.

Figure 5.

Figure 5.

(a) Schematics showing the synthesis of Fe3O4 nanocubes with edge lengths in the 9–80 nm range and (b) the growth mechanism of Fe3O4 nanocubes. Reproduced with permission from ref. [74]. Copyright 2019 American Chemical Society.

2.3. Other Geometries

The isotropic spherical geometry and anisotropic cubic geometry are two morphologies of Fe3O4 nanoparticles that have been extensively studied in synthesis and applications. Moreover, various anisotropic or special geometries of Fe3O4 nanoparticles have been synthesized, such as the 1D structures of nanorods and nanotubes and the 2D structures of nanoprisms, hexagonal nanoplates, multiarmed nanostars, tetrapods, and hollow nanoparticles [17]. Detailed descriptions of the sizes, morphologies, and related magnetic properties of these special geometries of Fe3O4 NPs are presented in Table 4.

Table 4.

Fe3O4 nanoparticles with special geometries and their magnetic properties.

Morphologies Size/Dimension (nm) Magnetic Properties (at 300 K) Ref.
Nanorods 63 × 6.5
140 × 12
MS = 20.01, HC = 46.53 [79]
Nanorods 41 × 7
65 × 5.7
56 × 10
MS = 86 emu/g
MS = 84 emu/g
MS = 87 emu/g
[40]
Nanorods 41 × 7 Ms = 86 emu/g, HC = 50 (Oe)
Nanorods 35 × 5.5
55 × 8
75 × 9
120 × 8
180 × 24
MS = 44 emu/g
MS = 53 emu/g
MS = 59 emu/g
MS = 55 emu/g, HC = 1100 Oe (10K)
HC = 850 Oe (10K)
[80]
Nanorods 310 × 135 Superparamagnetic [81]
Nanoplates Width (hexagonal): 120
Side length (triangular): 90
Thickness: 7
MS = 84.7 emu/g, HC = 117.72 Oe, MR = 13.36 emu/g [82]
Triangular nanoprisms Edge: 113
Thickness: 25
MS = 81.44 emu/g, HC = 126.29 Oe, MR = 11.29 emu/g [83]
Triangular nanoprisms Edge: 22
Thickness: 10
UN [84]
Hexagonal nanoplates Diameter: 200
Thickness: 20–30
MS = 51.4 emu/g, HC = 263 Oe, MR = 18.9 emu/g [85]
Multiarmed (bipod, tripod, and tetrapod) Diameter of arms: 100–200
Length of arms: up to 2 μm
MS = 106.6 emu/g, HC = 148.5 Oe, MR = 30.8 emu/g [86]
Hollow spheres Diameter: 16
Shell thickness: 3
UN [87]
Hollow spheres Diameter: 120 nm MS = 85.4 emu/g [88]
Hollow spheres Diameter: 295 nm MS = 76.7 emu/g [89]

For simple one-dimensional morphologies and highly anisotropic shapes, single-crystalline Fe3O4 nanorods were synthesized through the solvothermal synthesis of an iron pentacarbonyl precursor in octanol using hexadecylamine and oleic acid coordinating agents [79]. By adjusting the amount of hexadecylamine and reaction time, the sizes of nanorods or aspect ratios (length-to-diameter ratio) can be controlled. Two different sizes, length × diameter (L × D) of 65 × 6.5 nm and 140 × 12 nm, were observed with TEM, and HR-TEM images of the obtained Fe3O4 nanorods are shown in Figure 6a,b [79]. Separately, Das and coworkers synthesized Fe3O4 nanorods with different aspect ratios ranging from 5.6 to 11. They also reported the synthesis of Fe3O4 nanorods with comparable aspect ratios but different lengths and diameters [40]. A mechanistic study of the reaction revealed that Fe3O4 nanorods are formed by heteronucleation on intermediate FeO nanocubes [79]. In this reaction, Fe(CO)5 is first decomposed under solvothermal conditions to generate metallic iron. Then, metallic iron is oxidized by dissolved oxygen or other oxidizing species in the solution to form FeO nanocubes. At the same time, Fe(CO)5 reacts with oleic acid to form iron oleate simultaneously to the condensation of hexadecylamine and oleic acid to release water molecules for the hydrolysis of iron oleate. Combined with the dissolution of FeO, the decomposition of Fe(CO)5 and the hydrolysis of iron oleate provide the source for growing Fe3O4 nanorods. Applying this method, Chandra et al. fabricated epitaxial magnetite nanorods on a SrTiO3 substrate and observed enhanced room temperature magnetic anisotropy [90]. Nanorods of Fe3O4 have also been synthesized using a two-step process starting with the preparation of β-FeOOH nanorods before refluxing in oleylamine to form the Fe3O4 phase [80]. This method allows the preparation of nanorods with a wide range of controllable lengths from 35 to 180 nm, and the diameter can be tuned from 5.5 to 24 nm. Larger dextran-coated nanorods with average dimensions of L × D 310 × 135 nm were synthesized using a precipitation method [81]. Surprisingly, these large nanorods are retained in the superparamagnetic regime and have potential applications as spin–spin relaxation contrast agents and in monitoring peroxidase activity.

Figure 6.

Figure 6.

(a,b) TEM and HR-TEM images of Fe3O4 nanorods. Reproduced with permission from ref. [79]. Copyright 2012 American Chemical Society. (c,d) TEM and HR-TEM images of porous hollow NPs. Reproduced with permission from ref. [87]. Copyright 2009 American Chemical Society. (e) TEM image of 2D hexagonal nanoplates. Reproduced with permission from ref. [85]. Copyright 2010 American Chemical Society. (f,g) TEM images of Fe3O4 tripods and tetrapods. Reproduced with permission from ref. [86]. Copyright 2009 Elsevier.

Two-dimensional nanoplates of Fe3O4 with hexagonal or triangular geometries have also been synthesized using various different methods. Single-crystalline Fe3O4 nanoplates, consisting of triangular and hexagonal shapes, were synthesized with a facile template-free solvothermal method [82]. These nanoplates have an average thickness of ~7 nm, a mean width of ~120 nm for hexagonal shapes, and a ~90 nm side length for triangular shapes. Interestingly, due to the shape anisotropy of nanoplates, the nanoplates exhibit an extremely high coercivity of 117.72 Oe, which is higher than the coercive fields observed for spheres, polyhedral, solid, or hollow spheres (usually less than 110 Oe). Li et al. also applied a simple hydrothermal method using 1,3-propanediamine to prepare single-crystalline Fe3O4 triangular nanoprisms with an average edge length of 113 nm and a mean thickness of ~25 nm [83]. Triangular nanoprisms have also been synthesized by the decomposition of Fe(acac)3 in toluene using oleylamine as the surfactant and reducing agent [84]. In addition to wet syntheses, the supercritical fluid technique was also applied to synthesize Fe3O4 hexagonal nanoplatelets. This method utilized ferrocene as a precursor and supercritical carbon dioxide (sc-CO2) as the solvent and oxygen sources [85]. As shown in Figure 6e, the obtained hexagonal plates are uniform with a mean diameter of 200 nm and thickness ranging from 20 to 30 nm.

In addition to anisotropic shapes such as 1D nanorods and 2D nanoplates, a special geometry of multiarmed nanocrystals containing Y-shaped bipods, tripods, and tetrapods was successfully synthesized with a simple route using a mild hydrothermal protocol. This special geometry of multiarmed nanostructures exhibited an extremely high saturation magnetization of 106.6 emu/g, which is even higher than the maximum MS value of 92 emu/g for bulk magnetite [86]. TEM images of the tripod and tetrapod Fe3O4 nanocrystals are shown in Figure 6f,g, respectively. Moreover, a special version of the isotropic morphology of SNPs with hollow nanostructures was also synthesized [87,88]. Because they possess porous shells, these Fe3O4 hollow nanostructures are potentially useful for drug delivery applications. Separately, 19 nm porous hollow Fe3O4 nanoparticles were prepared through the controlled oxidation of Fe NPs, followed by an acid etching step [87]. The morphology and structure of these porous hollow NPs are presented in Figure 6c,d. Larger hollow Fe3O4 NPs with a mean diameter of 120 or 295 nm were also prepared using a direct solvothermal method or a combination of a solvothermal route and etching, respectively [88,89].

An atlas of synthetic strategies for synthesizing various geometries of magnetite nanoparticles, such as tetrahedrons, octahedrons, tetradecahedrons, cubes, and stars, was developed by Swihart and coworkers [76]. The authors proposed the growing mechanism of Fe3O4 nanocubes during the synthesis process and provided controllable growth procedures to obtain different geometries, such as tetrahedrons, octahedrons, and star shapes (cubic with sharply extruded corners), as shown in Figure 7.

Figure 7.

Figure 7.

Schematic illustration of the proposed growth model for MNCs. Reproduced with permission from ref. [76]. Copyright 2017 American Chemical Society.

Significant efforts have been made in the last 20 years to synthesize Fe3O4 nanoparticles with highly pure compositions, controllable sizes in a wide range, good uniform geometry, and high degrees of crystallinity. Furthermore, the in-depth mechanism of some synthetic protocols has been explained, which provides a better understanding of nanochemistry during synthesis processes and allows the tailoring of nanoparticle properties. In terms of synthesis, spherical Fe3O4 nanoparticles are relatively easily prepared and available in a wide range of sizes for use in various applications. Compared to spherical NPs, cubic Fe3O4 NPs show enhanced magnetic properties; however, the uniform growth of cubic crystals is more difficult to control. Although Fe3O4 nanorods possess large surface contact areas, they exhibit moderate magnetic properties. Some special geometries have excellent magnetic properties, such as 2D nanoplates with high coercivity and multiarmed nanocrystals with high saturation magnetization. Thus, this review provides a brief summary of the preparation of Fe3O4 NPs with specific sizes, geometries, and magnetic properties, which may be helpful for the preselection of synthetic routes for any target application.

3. Techniques for Characterizing Fe3O4 NPs

A combination of different methods is usually required to identify the composition and purity and evaluate the properties of Fe3O4 NPs. The most important aspect is to distinguish Fe3O4 from the maghemite phase and identify the compositional uniformity. Because the oxidation of Fe2+ to Fe3+ is a thermodynamically favored process, the coexistence of magnetite and maghemite phases is usually observed in Fe3O4 nanoparticles [56,91]. The presence of the maghemite phase in the magnetite nanoparticles may lead to a decrease in saturation magnetization. X-ray diffraction (XRD) is generally unable to distinguish between magnetite and maghemite phases due to similar patterns originating from the same cubic spinel structures [91]. However, two features that can be deduced from XRD are matching lattice parameters, and d-spacings have been used to further confirm the existence of the dominant magnetite phase [50,54,57]. For example, a slight difference in the standard lattice parameters of magnetite (8.396 Å) and maghemite (8.346 Å) has been identified [57]. X-ray photoelectron spectroscopy (XPS) is an effective method to prove the existence of the magnetite phase because of the coexistence of Fe2+ and Fe3+ cations [92]. Infrared spectroscopy [66,93] and Raman spectroscopy [94,95] are also widely used to assign and identify magnetite materials. For the quantitative analysis of the coexistence of different iron oxide phases in NPs, X-ray absorption spectroscopy (XAS) and X-ray magnetic circular dichroism spectroscopy (XMCD) have been used to quantitatively estimate the compositions of the mixture of maghemite and magnetite (γ-Fe2O3)1−x(Fe3O4)x, with the value of x ranging from 0.20 to 1.00 [56]. In addition to spectroscopic techniques, magnetic properties are also measured to characterize magnetite NPs. For example, magnetization versus temperature measurements reveal a kink at low temperature related to the Verwey transition of Fe3O4, while this feature does not occur in γ-Fe2O3. The Verwey transition in Fe3O4, which is usually observed for bulk magnetite at approximately 115–124 K, is also a good parameter to evaluate the level of crystallinity and match the stoichiometry of Fe3O4 NPs [41,96]. Hence, a combination of different characterization techniques is important to identify important factors that affect the magnetic properties of Fe3O4 NPs, such as the existence of the material phases, the uniformity of compositions, and the crystalline level.

4. Applications of Fe3O4 Nanoparticles

4.1. Biomedical Applications (Therapeutic and Diagnostic Technologies)

Combinations of excellent magnetic properties, inexpensive materials, great biocompatibility, and iron oxide have been widely investigated in various medical applications [35]. FDA approval for employing iron oxide nanoparticles as medical contrast agents for magnetic resonance imaging (MRI) indicates significant progress in applying magnetic iron oxide nanoparticles. Conventionally, magnetic contrast agents, hyperthermia, and drug delivery are the three most frequently explored biomedical applications of Fe3O4 nanoparticles. Furthermore, surface functionalization or preparation of bioconjugated Fe3O4-based substances has provided additional applications. We will introduce applications of Fe3O4 nanoparticles and their functionalized or core–shell structures in MRI, hyperthermia, and drug delivery. Moreover, we will highlight recent efforts in the preparation of multifunctional nanoparticles that integrate multiple applications in a single Fe3O4 nanoparticle-based system.

4.1.1. Contrast Agents for Magnetic Resonance Imaging (MRI)

Magnetic contrast agents for MRI are some of the most promising applications of iron oxide nanoparticles. Several commercial iron oxide nanoparticles are used as MRI contrast agents, such as Feridex (dextran-coated Fe3O4 and γ-Fe2O3), Resovist (carboxydextran-coated Fe3O4), and Combidex (dextran-coated Fe3O4) [9799]. Contrast agents have been used to enhance the contrast and improve the resolution of diagnostic MRI by reducing either the longitudinal (T1) or transverse (T2) relaxation time of water protons. Consequently, two types of contrast agents, T1 and T2, enhance the positive (bright signal) or negative (dark signal) contrast, respectively. As presented in Equations (1) and (2), the inverse of the relaxation time (1/T1 and 1/T2) is called the relaxation rate and is plotted as a function of the iron concentration to obtain linear lines. From those data, we are able to determine the slopes that are relaxivities r1 and r2, respectively. The higher the value for either r1 or r2, the better the contrast performance of T1 or T2 contrast agents, respectively. In addition, the ratio of relaxivities, r2/r1, can be used to evaluate the potential of a contrast agent, with lower values preferred for T1 agents and higher values for T2 agents. Although Fe3O4 nanoparticles have been extensively investigated as T2 contrast agents [100104], increasing efforts to use Fe3O4 nanoparticles as T1 contrast agents have been reported recently [98,105]. In-depth mechanisms of T1-weighted and T2-weighted contrast agents in MRI and criteria for NPs as efficient MRI contrast agents were discussed in previous reviews [97,98]. These investigations were conducted with both superparamagnetic and ferrimagnetic Fe3O4 NPs, usually including functionalized NPs or core–shell architectures for better colloidal stability and biocompatibility.

1T1=1T1([Fe]=0)+r1[Fe] (1)
1T2=1T2([Fe]=0)+r2[Fe] (2)

Different geometries, sizes, and nanostructures of Fe3O4-based nanoparticles have been investigated as MRI contrast agents. Lee et al. prepared ferrimagnetic uniform-sized Fe3O4 nanocubes with an edge length of 22 nm functionalized with PEG-phospholipids to provide excellent colloidal stability in aqueous media and great biocompatibility [106]. The colloid-containing functionalized 22 nm-sized Fe3O4 nanocubes exhibit a very high r2 relaxivity of 761 mM−1 s−1, which achieved the theoretically predicted maximum r2 relaxivity. Figure 8ad present the morphology of nanocubes, an image of a stable colloid, and in vivo images of tumors visualized with and without nanocube contrast agents. T2-weighted images produced with different sizes of nanocubes in various concentrations and their color-coded images are shown in Figure 8e,f. Separately, hyperbranched polyglycerol-grafted Fe3O4 NPs (size from 6 to 9 nm) were successfully synthesized with excellent colloidal stability in water, phosphate-buffered saline (PBS), and cell culture medium [107]. These NPs exhibit a contrast enhancement effect on T2-weighted sequences. Moreover, highly crystalline 8 nm Fe3O4 NPs were functionalized with an epoxy silane, (3-glycidyloxypropyl) trimethoxysilane, followed by the use of three-membered ring-opening chemistry to further graft polymers (e.g., polyetheramine and arginine) to the particle surface [108]. These functionalized NPs were highly dispersible in water and exhibited a high spin–lattice relaxivity r1 of 17 s−1 mM−1 and low r2/r1 ratios ranging from 3.3 to 3.8, which are good characteristics for T1 positive contrast agents. Bai and coworkers synthesized ultrasmall superparamagnetic Fe3O4 NPs modified with bull serum albumin and investigated these NPs as T1–T2 dual-modal MRI contrast agents in rabbit hepatic tumors [109]. In vivo experiments showed a rapid T2-weighted effect after 5 min, and T1 contrast enhancement appeared 90 min after intravenous administration. An Fe3O4-based dual-mode contrast agent for MRI and computed topography (CT) imaging was developed by Dheyab et al. [110]. In this study, Fe3O4@Au core–shell nanoparticles with a size of approximately 21 nm were prepared using a simple sonochemical method. The obtained core–shell NPs showed transverse relaxivity values of 222.28 mM−1 s−1 and have good potential for applications in MRI and CT imaging.

Figure 8.

Figure 8.

(a) TEM image of 22 nm nanocubes encapsulating PEG-phospholipid. (b) Image of colloidal iron oxide nanocubes. In vivo MR images of the tumor site: (c) without colloid injection and (d) after 1 h (intravenous injection). MR contrast effect of ferrimagnetic iron oxide nanocubes with different sizes: (e) T2-weighted MR images obtained with various concentrations of iron in a 3 T field and (f) their color-coded presentation. Reproduced with permission from ref. [106]. Copyright 2012 American Chemical Society.

4.1.2. Magnetic Hyperthermia

Magnetic hyperthermia has been documented as a promising therapeutic approach in cancer treatment. During these treatments, magnetic NPs provide heat to kill tumor cells in the presence of an alternating current (AC) magnetic field [34,111]. Tumor cells are destroyed upon the application of heat at 43 °C to 46 °C for a particular duration, while healthy cells are less affected by these treatments [112,113]. For safe clinical requirements, the product of the AC field amplitude and frequency should be smaller than 5 × 109 Am−1 s−1 [114]. Hence, Fe3O4 nanoparticles must meet two criteria to be utilized as an efficient hyperthermal agent. First, they should achieve high heating efficiency under the safe range of the AC field with a small dose of MNPs. Second, nanoparticles should form stable colloids that allow intravenous injection or delivery to tumors via the blood-stream. In addition, Fe3O4 NPs should be functionalized to enhance biocompatibility and colloidal stability or conjugated with recognition molecules for specific target molecules. Superparamagnetic NPs potentially represent a good candidate because they exhibit good dispersion and a lack of aggregation due to their negligible coercivity values and remnant magnetization. In contrast, SPM NPs can suffer from low heating power and require a high dose of materials due to low saturation magnetization. Although ferrimagnetic NPs exhibit high heating efficiency, stable colloids of these NPs are difficult to prepare due to the strong magnetic dipole interactions of ferromagnetic particles. The mechanism of heat generation is governed by the hysteresis loss mechanism for ferro- and ferrimagnetic NPs [35]. Meanwhile, Néel and Brown relaxations are the main heating mechanisms for superparamagnetic NPs. The specific absorption rate (SAR), also called the specific loss power (SLP), is measured by calculating the rate of absorbed energy per unit of mass in W/g to evaluate the heating efficiency of NPs.

Numerous studies have investigated the effects of the size, geometry, and anisotropic properties of magnetite NPs on their hyperthermia performance under different AC magnetic field conditions. In one study, 26 nm Fe3O4 spheres (diameter) and cubes (edge) prepared using solvothermal methods exhibited a much higher SAR value, especially when increasing the magnetic field amplitude [71]. A more comprehensive study of the effects of the Fe3O4 nanocrystal sizes and geometries on heating efficiency was conducted by Nemati et al. [41]. Spherical and cubic Fe3O4 NPs with sizes ranging from 10 to 100 nm were synthesized, and their heating efficiency was evaluated. At 800 Oe and 310 kHz, the optimum sizes of nanospheres for hyperthermia range from 30 to 50 nm (650 W/g), and nanocubes with sizes ranging from 30 to 35 nm are better heaters. Furthermore, the study suggested that nanocubes supply more heat than nanospheres with a size smaller than 35 nm, while nanospheres with a size larger than 35 nm are better heating agents. The hyperthermia performance of Fe3O4 nanocubes with sizes ranging from 13 to 40 nm was recorded at different magnetic field amplitudes from 2.3 to 30 kAm−1, with three different frequencies of 320, 520, and 720 kHz [52]. The 19 nm cubes show the highest SAR values at all frequencies, which can reach 2452 W/g at 520 kHz and 29 kAm−1. Additionally, studies of the magnetic properties showed that 19 nm nanocubes are located at the transition point from superparamagnetic to ferrimagnetic, consistent with the hypothesis proposed in previous studies for the higher SAR value of iron oxide nanoparticles in this transition size range [115]. Muro-Cruces and coworkers also compared the heating efficiency of nanocubes with sizes of 13, 15, and 19 nm and 22 nm spherical NPs at 17 kA/m and 183 kHz and obtained the best heating efficiency for 19 nm cubic Fe3O4 nanocrystals [74]. However, other measurements were conducted at different frequencies, such as 109, 220, and 300 kHz, for a similar size range (14 to 35 nm) of Fe3O4 nanocubes and produced a slightly different result [44]. Nanocubes with sizes of 19 and 24 nm showed the best SAR value under most of the measured conditions and saturated at approximately 18 kAm−1; however, 35 nm cubes showed higher SAR values at magnetic field amplitudes of 20–24 kAm−1. Das et al. synthesized Fe3O4 nanorods, nanocubes, and nanospheres with comparable volumes and determined that nanorods achieve a higher SAR value of 862 W/g, which is much higher than nanocubes (314 W/g) and nanospheres (140 W/g) [40]. Furthermore, increasing the aspect ratio of nanorods was proven to help increase the SAR value of magnetite nanorods. Thus, the heating efficiency of magnetite nanoparticles is affected by the shape and size of the nanoparticles and remarkably depends on the frequency and amplitude of the applied AC magnetic field.

Functionalization of Fe3O4 NPs or core–shell architectures was studied to further enhance the heating performance, biocompatibility, and stability of colloids. Bae et al. synthesized chitosan oligosaccharide-coated packs of four to ten 30 nm-sized Fe3O4 nanocubes and investigated the hyperthermia activity [116]. These particle cluster-coated chitosan nanoparticles exhibited a superior magnetic heating ability with a high specific loss power of 2614 W/g, which is much higher than that of commercial Feridex nanoparticles (83 W/g). Chitosan oligosaccharide was used to improve colloidal stability and blood circulation in vivo. Continuing the particle clustering strategy to enhance magnetic hyperthermia, Niculaes et al. studied the effect of individual nanocubes, dimers or trimers (two or three nanocubes), and centrosymmetric clusters (more than four nanocubes) on SAR values [117]. TEM images of monomers, dimers, trimers, and centrosymmetric clusters are shown in Figure 9ac. The prepared nanocubes stabilized with oleic acid were coated with the amphiphilic copolymer poly(styrene-comaleic anhydride). The degree of clustering was controlled by the ratio of polymer/surface area of nanocubes, as illustrated in Figure 9d. The SAR data shown in Figure 9e indicate that the dimers and trimers exhibit the best heating efficiency. In another study, Zyuzin et al. confined nanocubes inside submicrometer cavities to preserve magnetic heat losses in an intracellular environment [118]. Another study of 2D assemblies of magnetic nanocubes exploited enzymatic polymer disassembly to improve magnetic hyperthermia heat losses [119].

Figure 9.

Figure 9.

TEM images of colloidal nanoclusters constructed from Fe3O4 nanocube-coated amphiphilic copolymer poly(styrene-comaleic anhydride) to form (a) monomer clusters (1 nanocube), (b) dimers and trimers (2–3 nanocubes), and (c) centrosymmetric clusters (more than 4 nanocubes). (d) Schematic illustration of the preparation of soft colloidal nanoclusters. (e) SAR values for different soft colloidal nanoclusters. Reproduced with permission from ref. [117]. Copyright 2017 American Chemical Society.

Interestingly, Espinosa et al. utilized 20 nm Fe3O4 nanocubes with a dual capacity to act as both magnetic and photothermal agents [120]. Upon exposure to an AC magnetic field and near-infrared laser irradiation, an aqueous suspension of magnetite nanocubes achieved an unprecedented heating power up to 5000 W/g. The dual mode of magnetic hyperthermia and photothermia resulted in complete apoptosis-mediated cell death and complete solid tumor regression in vivo. Lavorato et al. synthesized monodisperse core–shell nanoparticles Fe3O4@CoxZn1−xFe2O4, and by controlling the thickness and composition of the shell, the water colloid of these NPs exhibited a large heating power up to 2400 W/g under an 80 mT magnetic field with a frequency of 309 kHz [121]. Lak and coworkers studied the phase transformation of 23 nm FeO@Fe3O4 core–shell nanocubes and their magnetic heating performance. This study identified the roles of subdomains of FeO, Fe2+ deficiencies, and structural defects in the up to 10-fold increase in the magnetic losses of the nanocubes, resulting in excellent heating efficiency compared to pure magnetite phase nanocubes [122]. Therefore, studies have shown that the sizes, geometries, and nanostructures of Fe3O4 NPs are three main factors that determine their magnetic heating capability.

4.1.3. Drug Delivery

An increasingly applied solution for the efficient utilization of drugs against target pathogens with minimum doses is drug delivery. Fe3O4 NPs are used as drug carriers in drug delivery applications due to the combinations of their multiple valuable properties, such as a strong magnetic response, low toxicity, biodegradability, biocompatibility, and inexpensiveness [123]. Furthermore, facile syntheses, easily functionalized surfaces for bioconjugate coatings or enhanced colloidal stability, and the capability to be guided under a magnetic field make Fe3O4 NPs an excellent candidate for drug delivery. In addition, the pristine magnetic properties for MRI imaging or hyperthermia of Fe3O4 can be integrated to achieve multifunctional NPs for drug delivery. Fe3O4 nanocarriers are usually functionalized with polymers (e.g., pH-responsive polymers) to control drug release, biomolecules for targeting ligand–receptor species, and biocompatible porous shells (e.g., SiO2) for drug loading. Cheng et al. prepared 16 nm porous hollow Fe3O4 NPs with opening pores of 2–4 nm for cisplatin (an anticancer drug) storage and release [87]. The release rate of the anticancer drug cisplatin increased further at pH values lower than 6 due to acidic etching of the NP pores. These NPs were also coupled with Herceptin to target breast cancer cells. Poly(acrylic acid) (PAA), a pH-responsive polymer, was loaded into hollow 200 nm-diameter Fe3O4 NPs to obtain the pH-triggered and magnetic-targeted drug delivery of the anticancer drug doxorubicin [124]. Moreover, rattle-type Fe3O4@SiO2 hollow mesoporous spheres were synthesized with different sizes and different thicknesses of the mesoporous shell using carbon templates [125]. These NPs showed no toxicity up to a concentration of 150 μg/mL and were able to load the anticancer drug doxorubicin hydrochloride into their hollow mesopores. Folic acid, a receptor-specific ligand for the targeted delivery of anticancer drugs, was further loaded on rattle-type Fe3O3@SiO2 hollow mesoporous spheres to achieve a combination of receptor-mediated targeting and magnetic targeting [126]. Qiu and coworkers introduced the ZnO interlayer as a microwave absorber, forming a novel Fe3O4@ZnO@SiO2 drug carrier that controls the release of cancer drugs upon exposure to microwave irradiation [127]. Special Janus nanocomposites with dual surface functionalization of polystyrene@Fe3O4@SiO2 were synthesized by Wang et al. for tumor cell targeting and stimulus-induced drug release [128]. Based on these examples, Fe3O4 nanoparticles with magnetic properties, facile synthesis of hollow nanostructures, and easily functionalized surfaces are promising platforms for drug delivery applications.

4.1.4. Multifunctional Nanoparticles in Biomedical Applications

The potential of applying Fe3O4 NPs in biomedical applications is not limited to single functional agents, such as contrast agents, heating agents (hyperthermia), or drug carrier nanospecies. Surface functionalization and core–shell structures of Fe3O4 NPs achieve multifunctional nanoagents with maximal activity in biomedical applications that integrate both therapeutic and diagnostic technologies in an Fe3O4 NP-based system. For example, MRI contrast agents and hyperthermia agents based on Fe3O4 nanostructures have also been used for drug delivery or integrated with biological substances and fluorescent molecules to enhance functionality in disease treatment and imaging. Immobilization of human tissue plasminogen activator (tPA) and bovine serum albumin on a cluster of multiple 20 nm Fe3O4 nanocubes was reported by Voros et al. for the preparation of multifunctional thrombolytic and MRI contrast nanoagents [129]. These nanoagents exhibited excellent thrombolytic activity and can potentially be applied for imaging vascular thrombi. The dissolution rate of clots was increased approximately 100-fold compared to free tPA due to the intimate interaction of tPA with the fibrin network and achieved an additional 10-fold increase through localized heating upon exposure to an alternating magnetic field. Lai and coworkers synthesized Fe3O4@SiO2 core–shell nanoparticles integrated with phosphorescent iridium complexes for three-in-one purposes of MRI, luminescence imaging, and photodynamic therapy [130]. Highly uniform superparamagnetic Fe3O4 NPs with an average size of 12 nm were coated with porous, biocompatible SiO2 shells before the iridium complexes were incorporated into the SiO2 matrix. Phosphorescent iridium complexes serve as dual functional agents, including photosensitizers, to generate singlet oxygen (1O2) for inducing cancer cell apoptosis and as luminescence agents for luminescence imaging. In a recent study aiming to prepare a dual-modality magnetic resonance and fluorescence unified imaging platform performed by Bao and colleagues [131], lipid-encapsulated Fe3O4 NPs were combined with dialkylcarbocyanine dyes before being integrated with surface peptide bioconjugation. The nanoprobes were used for stable, high-contrast MRI scans, near-infrared fluorescence imaging, and fluorescence microscopy.

A novel magnetic nanocatalyst constructed from glucose oxidase (GOD)-loaded Fe3O4 hollow NPs as starvation–chemodynamic–hyperthermia synergistic therapy for tumors was reported by Ying et al. [89]. Figure 10 illustrates the working principle of the nanocatalysts. Ferrous cations generate the reactive oxygen species (ROS) OH radicals from H2O2 via the Fenton reaction and subsequently induce cell apoptosis by chemodynamic therapy. GOD consumes glucose, which is an important nutrient in tumor tissues, resulting in tumor tissue starvation during therapy and the generation of an excess amount of H2O2 to further enhance the Fenton reaction in terms of chemodynamic activity. Moreover, GOD-loaded hollow Fe3O4 NPs can be heated under an AMF for hyperthermia treatment. In addition to utilizing Fe3O4 nanoparticles as the main core for further functionalization purposes, active MRI and hyperthermic Fe3O4 NPs have been grafted onto the surface of Er3+/Yb3+-doped NaYF4@SiO2@AuNP core–shell nanoparticles to obtain near-infrared and magnetic-responsive nanocomposites for hyperthermia treatment [132]. Combining an active optical heater Er3+/Yb3+-doped YPO4 nanophosphor with magnetic hyperthermia Fe3O4 agents into a hybrid material Er3+/Yb3+-doped YPO4@Fe3O4 enhances the hyperthermic activity and ability to recover the material [133].

Figure 10.

Figure 10.

(a) Synthetic scheme for GOD-encapsulated hollow iron oxide nanoparticles and (b) multifunctional therapeutic strategies for starvation–chemodynamic–hyperthermia using GOD-encapsulated hollow IONPs. Reproduced with permission from ref. [89]. Copyright 2020 American Chemical Society.

4.2. Biosensing

Magnetic nanoparticle-based solutions for biosensing have been widely studied, and significant progress has been achieved [7]. In general, magnetic NPs have been used for labeling magnetic signals for various biological sensing purposes such as biomolecular detections based on ligand–receptor binding of biological substances. In these systems, the magnetic NPs are functionalized for facile conjugation with biomarkers. The magnetic signals can be detected by different magnetic detection techniques including spintronic sensors, nuclear magnetic resonance sensors, atomic magnetometer-based sensors, and superconducting quantum interference devices. Various types of magnetic responses can be used for detection depending on the sensing purposes and detection techniques such as relaxation, remnant magnetization, susceptibility, induced 1H NMR, and frequency mixing. In-depth methods for functionalization of magnetic particles, strategies for bioconjugation, and designs of magnetic detection for magnetic particle-based biosensing platforms were summarized in the reviews of Chen et al. [7] and Hsing et al. [134].

Due to their strong magnetic properties, biocompatibility, and facile functionalized surface, Fe3O4 nanoparticles have been utilized in various biosensor platforms [135138]. Various biosensing platforms utilizing Fe3O4 NPs were summarized in the review by Kim et al. [139]. The magnetic properties, sizes, morphologies, and crystallinity of NPs are important factors defining the performance of Fe3O4 nanoparticle-based sensing systems. Lee and colleagues examined the biosensing performance of Fe3O4 nanoparticles from two aspects: the sizes and geometries of NPs (cubes and spheres) [42,43]. As an approach to study the size effect of NPs in biosensing, three different sizes of 120, 440, and 700 nm Fe3O4 nanospheres with comparable degrees of crystallinity (grain size ~17–18 nm) were synthesized, coated with SiO2, functionalized with poly(acrylic) acid (PAA) before conjugation with streptavidin, and utilized to detect specific proteins. As shown in Figure 11a, larger spherical NPs exhibit better magnetic signals and surprisingly better performance than commercial magnetic beads (2.8 μm size) in an experiment detecting the well-known streptavidin–biotin interaction. In addition, the streptavidin-conjugated magnetic NPs were further combined with an exchange-induced remnant magnetization (EXIRM) platform for the specific detection of two immunoglobulins G (IgG1 and IgG2a) bound to Protein A. Figure 11b shows a schematic illustrating protein-immunoglobulin exchange detection using EXIRM measurements. Protein A has a stronger affinity for IgG2a than IgG1. Therefore, Protein A is immobilized covalently on the glass surface and then attaches to biotinylated IgG1, followed by the attachment of streptavidin-coated NPs to bound biotinylated IgG1. With stronger affinity for Protein A, IgG2a is then introduced, causes an exchange reaction, and influences the magnetization signal. Figure 11c shows that larger MPs exhibit larger slopes, and magnetic NPs with a size of 120 nm show equivalent signals to commercial magnetic beads. The combination of the larger size and strong magnetic properties of functionalized NPs increases the sensitivity by up to 9-fold compared with commercial magnetic beads and achieves a high detection specificity.

Figure 11.

Figure 11.

(a) Magnetic signal of streptavidin-conjugated Fe3O4@SiO2@PAA NPs bound to a biotinylated surface. (b) Schematic illustration of the interaction between magnetic NPs and the surface for protein detection in the EXIRM analysis. (c) EXIRM data for Protein A arising from an exchange between IgG1 and IgG2 subclasses. Reproduced with permission from ref. [43]. Copyright 2018 American Chemical Society.

In addition to the importance of appropriate sizes in biosensing, the morphology of NPs has been identified as an important parameter for efficient biosensing performance. Kolhatkar et al. synthesized spherical and cubic Fe3O4 NPs with multiple domains and sizes ranging from 100 to 225 nm and studied their crystallinity, magnetic properties, and biosensing performance using force-induced remnant magnetization force spectroscopy (FIRMS). By comparing the magnetic properties of same-volume and same-body diagonal/diameter nanoparticles, cubic NPs exhibited 1.4–3.0 and 1.1–8.4 times higher values for saturation magnetization (MS) and coercivity (HC), respectively. The structural analysis revealed that the high crystallinity of nanocubes explained the enhanced magnetic properties. The author also functionalized these NPs with biotin and used FIRMS to study their binding to the streptavidin-modified surface. Upon applying a 1 pN force, the number of particles remaining on the functionalized surface and the magnetization response of the nanocubes were much better than those of the nanospheres, as indicated in Figure 12b,c. Thus, the increase in the signal and stronger attachment to the surface can be explained by the difference in magnetic strength and the contact surface area (Figure 12a).

Figure 12.

Figure 12.

(a) Schematic illustration of the contact area in the biosensing of nanocubic and nanospherical Fe3O4. FIRMS data showing the (b) magnetization profiles versus applied force of nanocubes and nanospheres with similar volumes and (c) number of retained nanoparticles on the sensor at 1 pN. Reproduced with permission from ref. [42]. Copyright 2017 American Chemical Society.

4.3. Environmental Applications

Fe3O4 nanoparticles and their nanoarchitectures have been utilized for applications in environmental treatments, such as heavy metal removal and adsorption/degradation of organic pollutants [18]. In these applications, Fe3O4 NPs have been used as supporting platforms that can easily be recovered/recycled by using magnetic separation techniques. Inexpensiveness, easy fabrication, biocompatibility, and easy separation/recovery by magnetic fields are the advantages of using Fe3O4 nanoparticles in environmental applications. However, easy agglomeration (for ferrimagnetic NPs) and oxidation are drawbacks that can be overcome by applying an appropriate surface coating layer or functionalized surface. The surface coating layer should be stable under harsh chemical conditions (e.g., acidic and basic conditions), have high thermal and mechanical stability, and be porous with a high loading capacity for pollutants. In general, magnetically loaded adsorbents are usually core–shell structures or composites of Fe3O4 with other oxides (e.g., SiO2, TiO2), carbon-based materials (carbon, carbon nanotubes, and graphene), and polymers or organic molecules with a good affinity for heavy metals or organic pollutants. Zhang et al. synthesized superparamagnetic Fe3O4@C core–shell nanoparticles with an average size of ~250 nm and studied the adsorption kinetics of two dyes, methylene blue (MB) and cresol red (CR) [140]. The prepared magnetic NPs are dispersible in an aqueous solution, easily separated from the solution using an external magnet, and have adsorption capacities for MB and CR of 44.38 mg/g and 11.22 mg/g, respectively. Separately, carboxylatopillar [5] arene-modified Fe3O4 nanoparticles synthesized using a one-pot solvothermal technique exhibit excellent cationic dye separation over a wide range of pH values and can be recycled by simple washing without decreasing the adsorption properties [141]. Khalaf examined the ability of Fe3O4 nanocubes coated with SiO2 and TiO2 to remove Cr(VI) [142]. Ren and coworkers also prepared ferrimagnetic Fe3O4@carbon composites and studied their performance in both removing the heavy metal Cr(VI) and organic pollutant Congo red [143]. Furthermore, Fe3O4-functionalized nanoparticles and composites have been applied to remove various heavy metal cations, such as Pb(II), Cd(II), Cu(II), Hg(II), As(III), and Cr(III) [144150], and organic pollutants, including rhodamine B, rhodamine 6G, methyl orange, and oil [151153]. Additionally, Fe3O4 NPs have been used as magnetic carriers for photocatalyst materials (e.g., TiO2) to promote the photocatalytic degradation of organic pollutants such as methylene blue and ofloxacin fluoroquinolone [154]. In general, Fe3O4 nanoparticles function as efficient magnetic carriers for absorbents or photocatalysts, which provide recyclability, reusability, nontoxicity, and inexpensive materials for large-scale wastewater treatments.

4.4. Energy Conversion and Storage Devices

Due to their various advantageous characteristics, such as low cost, natural abundance, ecofriendliness, electrochemical activity, and high theoretical capacity, Fe3O4 is a potentially useful anode material for supercapacitors and lithium-ion batteries. With good conductivity (102–103−1 cm−1) and a high theoretical capacitance (approximately 347 F/g at 1.2 V), Fe3O4 has been used in high-energy-density storage supercapacitors via redox reactions [20,155]. Nanostructured materials constructed from Fe3O4 NPs and carbon-based materials are promising hybrid materials that achieve a high energy density and robust electrochemical performance. Several hybrid nanostructures, including a 3D network of Fe3O4 NPs/reduced graphene oxide nanosheets [156], Fe3O4@carbon nanosheets [157], Fe3O4 nanosphere-decorated graphene [158], and Fe3O4 nanospheres coated with nitrogen-doped carbon [159], have produced encouraging results in the construction of high-performance supercapacitors. Using Fe3O4 as a conductive core, nanocomposites of conductive ferroelectric core–shell Fe3O4@BaTiO3 nanoparticles loaded into the ferroelectric poly(vinylidene fluoride-cohexafluoropropylene) (P-(VDF-HFP)) polymer matrix were prepared to increase the permittivity of the polymer and increase the degradation resistance of the polymerbased capacitor. The maximum energy storage density of this thin film reaches 7.018 J/cm3 upon exposure to an electric field of 2350 kV/cm [160]. Similar core–shell Fe3O4@BaTiO3 NPs were also incorporated into a PVDF polymer matrix and exhibited a remarkable energy density storage of 16 J/cc under an electric field of 430 kV/mm [161]. In addition to capacitor/supercapacitor applications, Fe3O4 NPs have been integrated into various nanoarchitectures/nanocomposites for use as anode materials for rechargeable lithium-ion batteries. In these systems, Fe3O4 participates in an electrochemical reaction with lithium, as indicated in Equation (3) below [162], which allows Li cation insertion/extraction. Theoretically, the capacity of Fe3O4 can reach ~900 mA h g−1, which is even higher than the capacity of commercial graphite (~372 mA h g−1). Optimizing the sizes and shapes of nanoparticles [163166] and fabricating carbon hybrid materials of Fe3O4 [167170] efficiently increase the conductivity, structural integrity, and performance of devices. Graphene nanosheet-wrapped Fe3O4 particles prepared by Zhou and coworkers showed improved stability and an excellent rate [168]. Wei et al. designed 3D graphene foams (GFs) cross-linked with graphene sheet (GS)-encapsulated Fe3O4 nanosphere Fe3O4@GS/GF, which exhibited a high reversible capacity of 1059 mAh g−1 over 150 cycles [171]. Thus, due to its superior properties, Fe3O4 represents a potential oxide material for integration into energy conversion and storage devices.

Electrochemical reaction (3):

Fe3O4+8Li++8e3Fe+4Li2O (3)

5. Conclusions

This review provides updates on recent progress and covers important aspects of applied Fe3O4 NPs, including structures and synthesis, magnetic properties, strategies for functionalization, and performance of Fe3O4-based NPs in various emerging applications. The size/geometry–property relationship of NPs, size/geometry-application relationship, and role of nanostructures in target applications were highlighted. The structures of Fe3O4 NPs (sizes and geometries) and magnetic properties are two important features that could be tailored by applying appropriate synthetic strategies. Consequently, the sizes and geometries of magnetic Fe3O4 NPs are very important structural factors that determine many properties of nanoparticles and their capabilities in various applications. This review also provides a limited atlas for the selection of suitable synthetic methods to obtain appropriate sizes, geometries, and magnetic properties of Fe3O4 NPs for target applications. Moreover, recent progress in applying Fe3O4 nanoparticles in emerging applications, such as diagnostic and therapeutic applications in the biomedical, biosensing, environmental, and energy storage fields, has been summarized. The exploitation of an appropriate structure of Fe3O4 NPs with the desired properties combined with the additional contribution of coating materials, functionalization of the surface, and special nanoarchitectures are crucial strategies to increase the performance of Fe3O4 NPs and achieve multifunctional NPs. Thus, the exploration of Fe3O4 NPs with different sizes, geometries, and integrated functionalities for multiple applications is an interesting field of research that still retains endless opportunities for discovery.

Acknowledgments:

We thank Hieu D. Nguyen for his assistance with the graphics.

Funding:

We thank the Air Force Office of Scientific Research (AFOSR FA9550-20-1-0349; 20RT0302, T.R.L.), the Robert A. Welch Foundation (E-1320, T.R.L.), the Texas Center for Superconductivity (T.R.L.), and the US National Institutes of Health (R01GM111452, S.X.) for generously supporting this research.

Footnotes

Conflicts of Interest: The authors have no competing financial interest to declare.

References

  • 1.Jeong U; Teng X; Wang Y; Yang H; Xia Y Superparamagnetic Colloids: Controlled Synthesis and Niche Applications. Adv. Mater 2007, 19, 33–60. [Google Scholar]
  • 2.Lu A-H; Salabas EL; Schüth F Magnetic Nanoparticles: Synthesis, Protection, Functionalization, and Application. Angew. Chem. Int. Ed 2007, 46, 1222–1244. [DOI] [PubMed] [Google Scholar]
  • 3.Singamaneni S; Bliznyuk VN; Binek C; Tsymbal EY Magnetic Nanoparticles: Recent Advances in Synthesis, Self-Assembly and Applications. J. Mater. Chem 2011, 21, 16819–16845. [Google Scholar]
  • 4.Frey NA; Peng S; Cheng K; Sun S Magnetic Nanoparticles: Synthesis, Functionalization, and Applications in Bioimaging and Magnetic Energy Storage. Chem. Soc. Rev 2009, 38, 2532–2542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Lisjak D; Mertelj A Anisotropic Magnetic Nanoparticles: A Review of Their Properties, Syntheses and Potential Applications. Prog. Mater. Sci 2018, 95, 286–328. [Google Scholar]
  • 6.Koh I; Josephson L Magnetic Nanoparticle Sensors. Sensors 2009, 9, 8130–8145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Chen Y-T; Kolhatkar AG; Zenasni O; Xu S; Lee TR Biosensing Using Magnetic Particle Detection Techniques. Sensors 2017, 17, 2300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Bilal M; Zhao Y; Rasheed T; Iqbal HMN Magnetic Nanoparticles as Versatile Carriers for Enzymes Immobilization: A Review. Int. J. Biol. Macromol 2018, 120, 2530–2544. [DOI] [PubMed] [Google Scholar]
  • 9.Wu K; Saha R; Su D; Krishna VD; Liu J; Cheeran MC-J; Wang J-P Magnetic-Nanosensor-Based Virus and Pathogen Detection Strategies before and during COVID-19. ACS Appl. Nano Mater 2020, 3, 9560–9580. [DOI] [PubMed] [Google Scholar]
  • 10.Colombo M; Carregal-Romero S; Casula MF; Gutiérrez L; Morales MP; Böhm IB; Heverhagen JT; Prosperi D; Parak WJ Biological Applications of Magnetic Nanoparticles. Chem. Soc. Rev 2012, 41, 4306–4334. [DOI] [PubMed] [Google Scholar]
  • 11.Srinoi P; Chen Y-T; Vittur V; Marquez MD; Lee TR Bimetallic Nanoparticles: Enhanced Magnetic and Optical Properties for Emerging Biological Applications. Appl. Sci 2018, 8, 1106. [Google Scholar]
  • 12.Laurent S; Forge D; Port M; Roch A; Robic C; Vander Elst L; Muller RN Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications. Chem. Rev 2008, 108, 2064–2110. [DOI] [PubMed] [Google Scholar]
  • 13.Ling D; Hyeon T Chemical Design of Biocompatible Iron Oxide Nanoparticles for Medical Applications. Small 2013, 9, 1450–1466. [DOI] [PubMed] [Google Scholar]
  • 14.Bobo D; Robinson KJ; Islam J; Thurecht KJ; Corrie SR Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date. Pharm. Res 2016, 33, 2373–2387. [DOI] [PubMed] [Google Scholar]
  • 15.Teja AS; Koh P-Y Synthesis, Properties, and Applications of Magnetic Iron Oxide Nanoparticles. Prog. Cryst. Growth Charact. Mater 2009, 55, 22–45. [Google Scholar]
  • 16.Phan M-H; Alonso J; Khurshid H; Lampen-Kelley P; Chandra S; Stojak Repa K; Nemati Z; Das R; Iglesias Ó; Srikanth H Exchange Bias Effects in Iron Oxide-Based Nanoparticle Systems. Nanomaterials 2016, 6, 221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Yang C; Wu J; Hou Y Fe3O4 Nanostructures: Synthesis, Growth Mechanism, Properties and Applications. Chem. Commun 2011, 47, 5130–5141. [DOI] [PubMed] [Google Scholar]
  • 18.Liu S; Yu B; Wang S; Shen Y; Cong H Preparation, Surface Functionalization and Application of Fe3O4 Magnetic Nanoparticles. Adv. Colloid Interface Sci 2020, 281, 102165. [DOI] [PubMed] [Google Scholar]
  • 19.Bohra M; Agarwal N; Singh V A Short Review on Verwey Transition in Nanostructured Fe3O4 Materials. J. Nanomater 2019, 2019, e8457383. [Google Scholar]
  • 20.Cornell RM; Schwertmann U The Iron Oxides: Structure, Properties, Reactions, Occurrences and Uses; John Wiley & Sons: New York, NY, USA, 2003; ISBN 978–3-527–30274-1. [Google Scholar]
  • 21.Klotz S; Steinle-Neumann G; Strässle T; Philippe J; Hansen T; Wenzel MJ Magnetism and the Verwey Transition in Fe3O4 under Pressure. Phys. Rev. B 2008, 77, 012411. [Google Scholar]
  • 22.Supattarasakda K; Petcharoen K; Permpool T; Sirivat A; Lerdwijitjarud W Control of Hematite Nanoparticle Size and Shape by the Chemical Precipitation Method. Powder Technol. 2013, 249, 353–359. [Google Scholar]
  • 23.Tadic M; Panjan M; Damnjanovic V; Milosevic I Magnetic Properties of Hematite (α-Fe2O3) Nanoparticles Prepared by Hydrothermal Synthesis Method. Appl. Surf. Sci 2014, 320, 183–187. [Google Scholar]
  • 24.Tadić M; Čitaković N; Panjan M; Stojanović Z; Marković D; Spasojević V Synthesis, Morphology, Microstructure and Magnetic Properties of Hematite Submicron Particles. J. Alloys Compd 2011, 509, 7639–7644. [Google Scholar]
  • 25.Revia RA; Zhang M Magnetite Nanoparticles for Cancer Diagnosis, Treatment, and Treatment Monitoring: Recent Advances. Mater. Today 2016, 19, 157–168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Gossuin Y; Gillis P; Hocq A; Vuong QL; Roch A Magnetic Resonance Relaxation Properties of Superparamagnetic Particles. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol 2009, 1, 299–310. [DOI] [PubMed] [Google Scholar]
  • 27.Miles PA; Westphal WB; Von Hippel A Dielectric Spectroscopy of Ferromagnetic Semiconductors. Rev. Mod. Phys 1957, 29, 279–307. [Google Scholar]
  • 28.Evans BJ Experimental Studies of the Electrical Conductivity and Phase Transition in Fe3O4. AIP Conf. Proc 1975, 24, 73. [Google Scholar]
  • 29.Rehman A; Daud A; Warsi MF; Shakir I; Agboola PO; Sarwar MI; Zulfiqar S Nanostructured Maghemite and Magnetite and Their Nanocomposites with Graphene Oxide for Photocatalytic Degradation of Methylene Blue. Mater. Chem. Phys 2020, 256, 123752. [Google Scholar]
  • 30.Guijarro N; Bornoz P; Prévot M; Yu X; Zhu X; Johnson M; Jeanbourquin X; Formal FL; Sivula K Evaluating Spinel Ferrites MFe2O4 (M = Cu, Mg, Zn) as Photoanodes for Solar Water Oxidation: Prospects and Limitations. Sustain. Energy Fuels 2018, 2, 103–117. [Google Scholar]
  • 31.Šutka A; Gross KA Spinel Ferrite Oxide Semiconductor Gas Sensors. Sens. Actuators B Chem 2016, 222, 95–105. [Google Scholar]
  • 32.Verwey EJW Electronic Conduction of Magnetite (Fe3O4) and Its Transition Point at Low Temperatures. Nature 1939, 144, 327–328. [Google Scholar]
  • 33.Tipsawat P; Wongpratat U; Phumying S; Chanlek N; Chokprasombat K; Maensiri S Magnetite (Fe3O4) Nanoparticles: Synthesis, Characterization and Electrochemical Properties. Appl. Surf. Sci 2018, 446, 287–292. [Google Scholar]
  • 34.Laurent S; Dutz S; Häfeli UO; Mahmoudi M Magnetic Fluid Hyperthermia: Focus on Superparamagnetic Iron Oxide Nanoparticles. Adv. Colloid Interface Sci 2011, 166, 8–23. [DOI] [PubMed] [Google Scholar]
  • 35.Figuerola A; Di Corato R; Manna L; Pellegrino T From Iron Oxide Nanoparticles towards Advanced Iron-Based Inorganic Materials Designed for Biomedical Applications. Pharmacol. Res 2010, 62, 126–143. [DOI] [PubMed] [Google Scholar]
  • 36.Ganapathe LS; Mohamed MA; Mohamad Yunus R; Berhanuddin DD Magnetite (Fe3O4) Nanoparticles in Biomedical Application: From Synthesis to Surface Functionalisation. Magnetochemistry 2020, 6, 68. [Google Scholar]
  • 37.Mirabello G; Lenders JJM; Sommerdijk NAJM Bioinspired Synthesis of Magnetite Nanoparticles. Chem. Soc. Rev 2016, 45, 5085–5106. [DOI] [PubMed] [Google Scholar]
  • 38.Yew YP; Shameli K; Miyake M; Ahmad Khairudin NBB; Mohamad SEB; Naiki T; Lee KX Green Biosynthesis of Superparamagnetic Magnetite Fe3O4 Nanoparticles and Biomedical Applications in Targeted Anticancer Drug Delivery System: A Review. Arab. J. Chem 2020, 13, 2287–2308. [Google Scholar]
  • 39.Siregar J; Septiani NLW; Abrori SA; Sebayang K; Irzaman; Fahmi MZ; Humaidi S; Sembiring T; Sembiring K; Yuliarto B Review—A Pollutant Gas Sensor Based On Fe3O4 Nanostructures: A Review. J. Electrochem. Soc 2021, 168, 027510. [Google Scholar]
  • 40.Das R; Alonso J; Nemati Porshokouh Z; Kalappattil V; Torres D; Phan M-H; Garaio E; García JÁ; Sanchez Llamazares JL; Srikanth H Tunable High Aspect Ratio Iron Oxide Nanorods for Enhanced Hyperthermia. J. Phys. Chem. C 2016, 120, 10086–10093. [Google Scholar]
  • 41.Nemati Z; Alonso J; Rodrigo I; Das R; Garaio E; García JÁ; Orue I; Phan M-H; Srikanth H Improving the Heating Efficiency of Iron Oxide Nanoparticles by Tuning Their Shape and Size. J. Phys. Chem. C 2018, 122, 2367–2381. [Google Scholar]
  • 42.Kolhatkar AG; Chen Y-T; Chinwangso P; Nekrashevich I; Dannangoda GC; Singh A; Jamison AC; Zenasni O; Rusakova IA; Martirosyan KS; et al. Magnetic Sensing Potential of Fe3O4 Nanocubes Exceeds That of Fe3O4 Nanospheres. ACS Omega 2017, 2, 8010–8019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Chen Y-T; Medhi R; Nekrashevich I; Litvinov D; Xu S; Lee TR Specific Detection of Proteins Using Exceptionally Responsive Magnetic Particles. Anal. Chem 2018, 90, 6749–6756. [DOI] [PubMed] [Google Scholar]
  • 44.Guardia P; Riedinger A; Nitti S; Pugliese G; Marras S; Genovese A; Elena Materia M; Lefevre C; Manna L; Pellegrino T One Pot Synthesis of Monodisperse Water Soluble Iron Oxide Nanocrystals with High Values of the Specific Absorption Rate. J. Mater. Chem. B 2014, 2, 4426–4434. [DOI] [PubMed] [Google Scholar]
  • 45.Kolhatkar AG; Jamison AC; Litvinov D; Willson RC; Lee TR Tuning the Magnetic Properties of Nanoparticles. Int. J. Mol. Sci 2013, 14, 15977–16009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Xuan S; Wang Y-XJ; Yu JC; Cham-Fai Leung K Tuning the Grain Size and Particle Size of Superparamagnetic Fe3O4 Microparticles. Chem. Mater 2009, 21, 5079–5087. [Google Scholar]
  • 47.Xuan S; Wang F; Wang Y-XJ; Yu JC; Leung KC-F Facile Synthesis of Size-Controllable Monodispersed Ferrite Nanospheres. J. Mater. Chem 2010, 20, 5086–5094. [Google Scholar]
  • 48.Deng H; Li X; Peng Q; Wang X; Chen J; Li Y Monodisperse Magnetic Single-Crystal Ferrite Microspheres. Angew. Chem. Int. Ed 2005, 44, 2782–2785. [DOI] [PubMed] [Google Scholar]
  • 49.Yang H; Ogawa T; Hasegawa D; Takahashi M Synthesis and Magnetic Properties of Monodisperse Magnetite Nanocubes. J. Appl. Phys 2008, 103, 07D526. [Google Scholar]
  • 50.Kim D; Lee N; Park M; Kim BH; An K; Hyeon T Synthesis of Uniform Ferrimagnetic Magnetite Nanocubes. J. Am. Chem. Soc 2009, 131, 454–455. [DOI] [PubMed] [Google Scholar]
  • 51.Krishnan KM Biomedical Nanomagnetics: A Spin Through Possibilities in Imaging, Diagnostics, and Therapy. IEEE Trans. Magn 2010, 46, 2523–2558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Guardia P; Di Corato R; Lartigue L; Wilhelm C; Espinosa A; Garcia-Hernandez M; Gazeau F; Manna L; Pellegrino T Water-Soluble Iron Oxide Nanocubes with High Values of Specific Absorption Rate for Cancer Cell Hyperthermia Treatment. ACS Nano 2012, 6, 3080–3091. [DOI] [PubMed] [Google Scholar]
  • 53.Ge J; Hu Y; Biasini M; Beyermann WP; Yin Y Superparamagnetic Magnetite Colloidal Nanocrystal Clusters. Angew. Chem. Int. Ed 2007, 46, 4342–4345. [DOI] [PubMed] [Google Scholar]
  • 54.Sun S; Zeng H Size-Controlled Synthesis of Magnetite Nanoparticles. J. Am. Chem. Soc 2002, 124, 8204–8205. [DOI] [PubMed] [Google Scholar]
  • 55.Sun S; Zeng H; Robinson DB; Raoux S; Rice PM; Wang SX; Li G Monodisperse MFe2O4 (M = Fe, Co, Mn) Nanoparticles. J. Am. Chem. Soc 2004, 126, 273–279. [DOI] [PubMed] [Google Scholar]
  • 56.Park J; An K; Hwang Y; Park J-G; Noh H-J; Kim J-Y; Park J-H; Hwang N-M; Hyeon T Ultra-Large-Scale Syntheses of Monodisperse Nanocrystals. Nat. Mater 2004, 3, 891–895. [DOI] [PubMed] [Google Scholar]
  • 57.Xu Z; Shen C; Hou Y; Gao H; Sun S Oleylamine as Both Reducing Agent and Stabilizer in a Facile Synthesis of Magnetite Nanoparticles. Chem. Mater 2009, 21, 1778–1780. [Google Scholar]
  • 58.Lee K; Lee S; Oh MC; Ahn B Alkaline Metal Reagent-Assisted Synthesis of Monodisperse Iron Oxide Nanostructures. Metals 2018, 8, 107. [Google Scholar]
  • 59.Hou Y; Yu J; Gao S Solvothermal Reduction Synthesis and Characterization of Superparamagnetic Magnetite Nanoparticles. J. Mater. Chem 2003, 13, 1983–1987. [Google Scholar]
  • 60.Li Z; Sun Q; Gao M Preparation of Water-Soluble Magnetite Nanocrystals from Hydrated Ferric Salts in 2-Pyrrolidone: Mechanism Leading to Fe3O4. Angew. Chem. Int. Ed 2005, 44, 123–126. [DOI] [PubMed] [Google Scholar]
  • 61.Ge S; Shi X; Sun K; Li C; Uher C; Baker JR; Banaszak Holl MM; Orr BG Facile Hydrothermal Synthesis of Iron Oxide Nanoparticles with Tunable Magnetic Properties. J. Phys. Chem. C 2009, 113, 13593–13599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Guardia P; Labarta A; Batlle X Tuning the Size, the Shape, and the Magnetic Properties of Iron Oxide Nanoparticles. J. Phys. Chem. C 2011, 115, 390–396. [Google Scholar]
  • 63.Caruntu D; Caruntu G; O’Connor CJ Magnetic Properties of Variable-Sized Fe3O4 Nanoparticles Synthesized from Non-Aqueous Homogeneous Solutions of Polyols. J. Phys. D Appl. Phys 2007, 40, 5801–5809. [Google Scholar]
  • 64.Nazrul Islam M; Van Phong L; Jeong J-R; Kim C A Facile Route to Sonochemical Synthesis of Magnetic Iron Oxide (Fe3O4) Nanoparticles. Thin Solid Films 2011, 519, 8277–8279. [Google Scholar]
  • 65.Hou Y; Xu Z; Sun S Controlled Synthesis and Chemical Conversions of FeO Nanoparticles. Angew. Chem. Int. Ed 2007, 46, 6329–6332. [DOI] [PubMed] [Google Scholar]
  • 66.Si S; Kotal A; Mandal TK; Giri S; Nakamura H; Kohara T Size-Controlled Synthesis of Magnetite Nanoparticles in the Presence of Polyelectrolytes. Chem. Mater 2004, 16, 3489–3496. [Google Scholar]
  • 67.Zhuang J; Wu H; Yang Y; Cao YC Supercrystalline Colloidal Particles from Artificial Atoms. J. Am. Chem. Soc 2007, 129, 14166–14167. [DOI] [PubMed] [Google Scholar]
  • 68.Zhuang J; Wu H; Yang Y; Cao YC Controlling Colloidal Superparticle Growth Through Solvophobic Interactions. Angew. Chem. Int. Ed 2008, 47, 2208–2212. [DOI] [PubMed] [Google Scholar]
  • 69.Rittikulsittichai S; Kolhatkar AG; Sarangi S; Vorontsova MA; Vekilov PG; Brazdeikis A; Lee TR Multi-Responsive Hybrid Particles: Thermo-, PH-, Photo-, and Magneto-Responsive Magnetic Hydrogel Cores with Gold Nanorod Optical Triggers. Nanoscale 2016, 8, 11851–11861. [DOI] [PubMed] [Google Scholar]
  • 70.Liu Y; Cui T; Li Y; Zhao Y; Ye Y; Wu W; Tong G Effects of Crystal Size and Sphere Diameter on Static Magnetic and Electromagnetic Properties of Monodisperse Fe3O4 Microspheres. Mater. Chem. Phys 2016, 173, 152–160. [Google Scholar]
  • 71.Elsayed WEM; Al-Hazmi FS; Memesh LS; Bronstein LM A Novel Approach for Rapid Green Synthesis of Nearly Mono-Disperse Iron Oxide Magnetic Nanocubes with Remarkable Surface Magnetic Anisotropy Density for Enhancing Hyperthermia Performance. Colloids Surf. A Physicochem. Eng. Asp 2017, 529, 239–245. [Google Scholar]
  • 72.Guardia P; Pérez-Juste J; Labarta A; Batlle X; Liz-Marzán LM Heating Rate Influence on the Synthesis of Iron Oxide Nanoparticles: The Case of Decanoic Acid. Chem. Commun 2010, 46, 6108–6110. [DOI] [PubMed] [Google Scholar]
  • 73.Kovalenko MV; Bodnarchuk MI; Lechner RT; Hesser G; Schäffler F; Heiss W Fatty Acid Salts as Stabilizers in Size- and Shape-Controlled Nanocrystal Synthesis: The Case of Inverse Spinel Iron Oxide. J. Am. Chem. Soc 2007, 129, 6352–6353. [DOI] [PubMed] [Google Scholar]
  • 74.Muro-Cruces J; Roca AG; López-Ortega A; Fantechi E; del-Pozo-Bueno D; Estradé S; Peiró F; Sepúlveda B; Pineider F; Sangregorio C; et al. Precise Size Control of the Growth of Fe3O4 Nanocubes over a Wide Size Range Using a Rationally Designed One-Pot Synthesis. ACS Nano 2019, 13, 7716–7728. [DOI] [PubMed] [Google Scholar]
  • 75.Abbas M; Takahashi M; Kim C Facile Sonochemical Synthesis of High-Moment Magnetite (Fe3O4) Nanocube. J. Nanopart. Res 2012, 15, 1354. [Google Scholar]
  • 76.Qiao L; Fu Z; Li J; Ghosen J; Zeng M; Stebbins J; Prasad PN; Swihart MT Standardizing Size- and Shape-Controlled Synthesis of Monodisperse Magnetite (Fe3O4) Nanocrystals by Identifying and Exploiting Effects of Organic Impurities. ACS Nano 2017, 11, 6370–6381. [DOI] [PubMed] [Google Scholar]
  • 77.Abbas M; Ramulu Torati S; Kim C A Novel Approach for the Synthesis of Ultrathin Silica-Coated Iron Oxide Nanocubes Decorated with Silver Nanodots (Fe3O4/SiO2/Ag) and Their Superior Catalytic Reduction of 4-Nitroaniline. Nanoscale 2015, 7, 12192–12204. [DOI] [PubMed] [Google Scholar]
  • 78.Vergés MA; Costo R; Roca AG; Marco JF; Goya GF; Serna CJ; Morales MP Uniform and Water Stable Magnetite Nanoparticles with Diameters around the Monodomain–Multidomain Limit. J. Phys. D Appl. Phys 2008, 41, 134003. [Google Scholar]
  • 79.Sun H; Chen B; Jiao X; Jiang Z; Qin Z; Chen D Solvothermal Synthesis of Tunable Electroactive Magnetite Nanorods by Controlling the Side Reaction. J. Phys. Chem. C 2012, 116, 5476–5481. [Google Scholar]
  • 80.Mitra A; Mohapatra J; Sharma H; Meena SS; Aslam M Controlled Synthesis and Enhanced Tunnelling Magnetoresistance in Oriented Fe3O4 Assemblies. J. Phys. D Appl. Phys 2018, 51, 085002. [Google Scholar]
  • 81.Nath S; Kaittanis C; Ramachandran V; Dalal NS; Perez JM Synthesis, Magnetic Characterization, and Sensing Applications of Novel Dextran-Coated Iron Oxide Nanorods. Chem. Mater 2009, 21, 1761–1767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Zhang W-D; Xiao H-M; Zhu L-P; Fu S-Y Template-Free Solvothermal Synthesis and Magnetic Properties of Novel Single-Crystalline Magnetite Nanoplates. J. Alloys Compd 2009, 477, 736–738. [Google Scholar]
  • 83.Li X; Si Z; Lei Y; Tang J; Wang S; Su S; Song S; Zhao L; Zhang H Direct Hydrothermal Synthesis of Single-Crystalline Triangular Fe3O4 Nanoprisms. CrystEngComm 2010, 12, 2060–2063. [Google Scholar]
  • 84.Zeng Y; Hao R; Xing B; Hou Y; Xu Z One-Pot Synthesis of Fe3O4 Nanoprisms with Controlled Electrochemical Properties. Chem. Commun 2010, 46, 3920–3922. [DOI] [PubMed] [Google Scholar]
  • 85.Li Z; Godsell JF; O’Byrne JP; Petkov N; Morris MA; Roy S; Holmes JD Supercritical Fluid Synthesis of Magnetic Hexagonal Nanoplatelets of Magnetite. J. Am. Chem. Soc 2010, 132, 12540–12541. [DOI] [PubMed] [Google Scholar]
  • 86.Gu L; Shen H Facile One-Pot Synthesis of Multi-Armed Fe3O4 Nanocrystals. J. Alloys Compd 2009, 472, 50–54. [Google Scholar]
  • 87.Cheng K; Peng S; Xu C; Sun S Porous Hollow Fe3O4 Nanoparticles for Targeted Delivery and Controlled Release of Cisplatin. J. Am. Chem. Soc 2009, 131, 10637–10644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Li D; Tang J; Guo J; Wang S; Chaudhary D; Wang C Hollow-Core Magnetic Colloidal Nanocrystal Clusters with Ligand-Exchanged Surface Modification as Delivery Vehicles for Targeted and Stimuli-Responsive Drug Release. Chem. Eur. J 2012, 18, 16517–16524. [DOI] [PubMed] [Google Scholar]
  • 89.Ying W; Zhang Y; Gao W; Cai X; Wang G; Wu X; Chen L; Meng Z; Zheng Y; Hu B; et al. Hollow Magnetic Nanocatalysts Drive Starvation–Chemodynamic–Hyperthermia Synergistic Therapy for Tumor. ACS Nano 2020, 14, 9662–9674. [DOI] [PubMed] [Google Scholar]
  • 90.Chandra S; Das R; Kalappattil V; Eggers T; Harnagea C; Nechache R; Phan M-H; Rosei F; Srikanth H Epitaxial Magnetite Nanorods with Enhanced Room Temperature Magnetic Anisotropy. Nanoscale 2017, 9, 7858–7867. [DOI] [PubMed] [Google Scholar]
  • 91.Demortière A; Panissod P; Pichon BP; Pourroy G; Guillon D; Donnio B; Bégin-Colin S Size-Dependent Properties of Magnetic Iron Oxide Nanocrystals. Nanoscale 2011, 3, 225–232. [DOI] [PubMed] [Google Scholar]
  • 92.Grosvenor AP; Kobe BA; Biesinger MC; McIntyre NS Investigation of Multiplet Splitting of Fe 2p XPS Spectra and Bonding in Iron Compounds. Surf. Interface Anal 2004, 36, 1564–1574. [Google Scholar]
  • 93.Roca AG; Marco JF; Morales MDP; Serna CJ Effect of Nature and Particle Size on Properties of Uniform Magnetite and Maghemite Nanoparticles. J. Phys. Chem. C 2007, 111, 18577–18584. [Google Scholar]
  • 94.Soler MAG; Qu F Raman Spectroscopy of Iron Oxide Nanoparticles. In Raman Spectroscopy for Nanomaterials Characterization; Kumar CSSR, Ed.; Springer: Berlin/Heidelberg, Germany, 2012; pp. 379–416. ISBN 978–3-642–20620-7. [Google Scholar]
  • 95.Shebanova ON; Lazor P Raman Study of Magnetite (Fe3O4): Laser-Induced Thermal Effects and Oxidation. J. Raman Spectrosc 2003, 34, 845–852. [Google Scholar]
  • 96.Prozorov R; Prozorov T; Mallapragada SK; Narasimhan B; Williams TJ; Bazylinski DA Magnetic Irreversibility and the Verwey Transition in Nanocrystalline Bacterial Magnetite. Phys. Rev. B 2007, 76, 054406. [Google Scholar]
  • 97.Na HB; Song IC; Hyeon T Inorganic Nanoparticles for MRI Contrast Agents. Adv. Mater 2009, 21, 2133–2148. [Google Scholar]
  • 98.Jeon M; Halbert MV; Stephen ZR; Zhang M Iron Oxide Nanoparticles as T1 Contrast Agents for Magnetic Resonance Imaging: Fundamentals, Challenges, Applications, and Prospectives. Adv. Mater 2021, 33, 1906539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Li L; Jiang W; Luo K; Song H; Lan F; Wu Y; Gu Z Superparamagnetic Iron Oxide Nanoparticles as MRI Contrast Agents for Non-Invasive Stem Cell Labeling and Tracking. Theranostics 2013, 3, 595–615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Beg MS; Mohapatra J; Pradhan L; Patkar D; Bahadur D Porous Fe3O4-SiO2 Core-Shell Nanorods as High-Performance MRI Contrast Agent and Drug Delivery Vehicle. J. Magn. Magn. Mater 2017, 428, 340–347. [Google Scholar]
  • 101.Wu H; Liu G; Zhuang Y; Wu D; Zhang H; Yang H; Hu H; Yang S The Behavior after Intravenous Injection in Mice of Multiwalled Carbon Nanotube/Fe3O4 Hybrid MRI Contrast Agents. Biomaterials 2011, 32, 4867–4876. [DOI] [PubMed] [Google Scholar]
  • 102.Fang W; Zhu W; Chen H; Zhang H; Hong S; Wei W; Zhao T MRI Enhancement and Tumor Targeted Drug Delivery Using Zn2+-Doped Fe3O4 Core/Mesoporous Silica Shell Nanocomposites. ACS Appl. Bio Mater 2020, 3, 1690–1697. [DOI] [PubMed] [Google Scholar]
  • 103.Wang X; Pan F; Xiang Z; Jia W; Lu W Magnetic Fe3O4@PVP Nanotubes with High Heating Efficiency for MRI-Guided Magnetic Hyperthermia Applications. Mater. Lett 2020, 262, 127187. [Google Scholar]
  • 104.Clements TW; Sarsons C; Platnich CM; Banerjee A; Blasiak B; Tomanek B; Rinker KD; Trudel S Maltol-Functionalized Fe3O4 Nanoparticles as T2 Magnetic Resonance Imaging Contrast Agents. ChemistrySelect 2016, 1, 1602–1606. [Google Scholar]
  • 105.Zhang G; Zhang L; Si Y; Li Q; Xiao J; Wang B; Liang C; Wu Z; Tian G Oxygen-Enriched Fe3O4/Gd2O3 Nanopeanuts for Tumor-Targeting MRI and ROS-Triggered Dual-Modal Cancer Therapy through Platinum (IV) Prodrugs Delivery. Chem. Eng. J 2020, 388, 124269. [Google Scholar]
  • 106.Lee N; Choi Y; Lee Y; Park M; Moon WK; Choi SH; Hyeon T Water-Dispersible Ferrimagnetic Iron Oxide Nanocubes with Extremely High R2 Relaxivity for Highly Sensitive in Vivo MRI of Tumors. Nano Lett. 2012, 12, 3127–3131. [DOI] [PubMed] [Google Scholar]
  • 107.Wang L; Neoh KG; Kang ET; Shuter B; Wang S-C Superparamagnetic Hyperbranched Polyglycerol-Grafted Fe3O4 Nanoparticles as a Novel Magnetic Resonance Imaging Contrast Agent: An In Vitro Assessment. Adv. Funct. Mater 2009, 19, 2615–2622. [Google Scholar]
  • 108.Ninjbadgar T; Brougham DF Epoxy Ring Opening Phase Transfer as a General Route to Water Dispersible Superparamagnetic Fe3O4 Nanoparticles and Their Application as Positive MRI Contrast Agents. Adv. Funct. Mater 2011, 21, 4769–4775. [Google Scholar]
  • 109.Bai C; Hu P; Liu N; Feng G; Liu D; Chen Y; Ma M; Gu N; Zhang Y Synthesis of Ultrasmall Fe3O4 Nanoparticles as T1–T2 Dual-Modal Magnetic Resonance Imaging Contrast Agents in Rabbit Hepatic Tumors. ACS Appl. Nano Mater 2020, 3, 3585–3595. [Google Scholar]
  • 110.Dheyab MA; Aziz AA; Jameel MS; Noqta OA; Khaniabadi PM; Mehrdel B Excellent Relaxivity and X-Ray Attenuation Combo Properties of Fe3O4@Au CSNPs Produced via Rapid Sonochemical Synthesis for MRI and CT Imaging. Mater. Today Commun 2020, 25, 101368. [Google Scholar]
  • 111.Obaidat IM; Issa B; Haik Y Magnetic Properties of Magnetic Nanoparticles for Efficient Hyperthermia. Nanomaterials 2015, 5, 63–89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 112.Jordan A; Scholz R; Wust P; Schirra H; Thomas S; Schmidt H; Felix R Endocytosis of Dextran and Silan-Coated Magnetite Nanoparticles and the Effect of Intracellular Hyperthermia on Human Mammary Carcinoma Cells in Vitro. J. Magn. Magn. Mater 1999, 194, 185–196. [Google Scholar]
  • 113.Moroz P; Jones SK; Gray BN Magnetically Mediated Hyperthermia: Current Status and Future Directions. Int. J. Hyperth 2002, 18, 267–284. [DOI] [PubMed] [Google Scholar]
  • 114.Hergt R; Dutz S Magnetic Particle Hyperthermia—Biophysical Limitations of a Visionary Tumour Therapy. J. Magn. Magn. Mater 2007, 311, 187–192. [Google Scholar]
  • 115.Hergt R; Dutz S; Müller R; Zeisberger M Magnetic Particle Hyperthermia: Nanoparticle Magnetism and Materials Development for Cancer Therapy. J. Phys. Condens. Matter 2006, 18, S2919–S2934. [Google Scholar]
  • 116.Bae KH; Park M; Do MJ; Lee N; Ryu JH; Kim GW; Kim C; Park TG; Hyeon T Chitosan Oligosaccharide-Stabilized Ferrimagnetic Iron Oxide Nanocubes for Magnetically Modulated Cancer Hyperthermia. ACS Nano 2012, 6, 5266–5273. [DOI] [PubMed] [Google Scholar]
  • 117.Niculaes D; Lak A; Anyfantis GC; Marras S; Laslett O; Avugadda SK; Cassani M; Serantes D; Hovorka O; Chantrell R; et al. Asymmetric Assembling of Iron Oxide Nanocubes for Improving Magnetic Hyperthermia Performance. ACS Nano 2017, 11, 12121–12133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118.Zyuzin MV; Cassani M; Barthel MJ; Gavilan H; Silvestri N; Escudero A; Scarpellini A; Lucchesi F; Teran FJ; Parak WJ; et al. Confining Iron Oxide Nanocubes inside Submicrometric Cavities as a Key Strategy to Preserve Magnetic Heat Losses in an Intracellular Environment. ACS Appl. Mater. Interfaces 2019, 11, 41957–41971. [DOI] [PubMed] [Google Scholar]
  • 119.Avugadda SK; Materia ME; Nigmatullin R; Cabrera D; Marotta R; Cabada TF; Marcello E; Nitti S; Artés-Ibañez EJ; Basnett P; et al. Esterase-Cleavable 2D Assemblies of Magnetic Iron Oxide Nanocubes: Exploiting Enzymatic Polymer Disassembling to Improve Magnetic Hyperthermia Heat Losses. Chem. Mater 2019, 31, 5450–5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 120.Espinosa A; Di Corato R; Kolosnjaj-Tabi J; Flaud P; Pellegrino T; Wilhelm C Duality of Iron Oxide Nanoparticles in Cancer Therapy: Amplification of Heating Efficiency by Magnetic Hyperthermia and Photothermal Bimodal Treatment. ACS Nano 2016, 10, 2436–2446. [DOI] [PubMed] [Google Scholar]
  • 121.Lavorato GC; Das R; Xing Y; Robles J; Litterst FJ; Baggio-Saitovitch E; Phan M-H; Srikanth H Origin and Shell-Driven Optimization of the Heating Power in Core/Shell Bimagnetic Nanoparticles. ACS Appl. Nano Mater 2020, 3, 1755–1765. [Google Scholar]
  • 122.Lak A; Cassani M; Mai BT; Winckelmans N; Cabrera D; Sadrollahi E; Marras S; Remmer H; Fiorito S; Cremades-Jimeno L; et al. Fe2+ Deficiencies, FeO Subdomains, and Structural Defects Favor Magnetic Hyperthermia Performance of Iron Oxide Nanocubes into Intracellular Environment. Nano Lett. 2018, 18, 6856–6866. [DOI] [PubMed] [Google Scholar]
  • 123.Shen L; Li B; Qiao Y Fe3O4 Nanoparticles in Targeted Drug/Gene Delivery Systems. Materials 2018, 11, 324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124.Kang X-J; Dai Y-L; Ma P-A; Yang D-M; Li C-X; Hou Z-Y; Cheng Z-Y; Lin J Poly(Acrylic Acid)-Modified Fe3O4 Microspheres for Magnetic-Targeted and PH-Triggered Anticancer Drug Delivery. Chem. Eur. J 2012, 18, 15676–15682. [DOI] [PubMed] [Google Scholar]
  • 125.Zhu Y; Ikoma T; Hanagata N; Kaskel S Rattle-Type Fe3O4@SiO2 Hollow Mesoporous Spheres as Carriers for Drug Delivery. Small 2010, 6, 471–478. [DOI] [PubMed] [Google Scholar]
  • 126.Zhu Y; Fang Y; Kaskel S Folate-Conjugated Fe3O4@SiO2 Hollow Mesoporous Spheres for Targeted Anticancer Drug Delivery. J. Phys. Chem. C 2010, 114, 16382–16388. [Google Scholar]
  • 127.Qiu H; Cui B; Li G; Yang J; Peng H; Wang Y; Li N; Gao R; Chang Z; Wang Y Novel Fe3O4@ZnO@mSiO2 Nanocarrier for Targeted Drug Delivery and Controllable Release with Microwave Irradiation. J. Phys. Chem. C 2014, 118, 14929–14937. [Google Scholar]
  • 128.Wang F; Pauletti GM; Wang J; Zhang J; Ewing RC; Wang Y; Shi D Dual Surface-Functionalized Janus Nanocomposites of Polystyrene/Fe3O4@SiO2 for Simultaneous Tumor Cell Targeting and Stimulus-Induced Drug Release. Adv. Mater 2013, 25, 3485–3489. [DOI] [PubMed] [Google Scholar]
  • 129.Voros E; Cho M; Ramirez M; Palange AL; Rosa ED; Key J; Garami Z; Lumsden AB; Decuzzi P TPA Immobilization on Iron Oxide Nanocubes and Localized Magnetic Hyperthermia Accelerate Blood Clot Lysis. Adv. Funct. Mater 2015, 25, 1709–1718. [Google Scholar]
  • 130.Lai C-W; Wang Y-H; Lai C-H; Yang M-J; Chen C-Y; Chou P-T; Chan C-S; Chi Y; Chen Y-C; Hsiao J-K Iridium-Complex-Functionalized Fe3O4/SiO2 Core/Shell Nanoparticles: A Facile Three-in-One System in Magnetic Resonance Imaging, Luminescence Imaging, and Photodynamic Therapy. Small 2008, 4, 218–224. [DOI] [PubMed] [Google Scholar]
  • 131.Zhang L; Tong S; Zhang Q; Bao G Lipid-Encapsulated Fe3O4 Nanoparticles for Multimodal Magnetic Resonance/Fluorescence Imaging. ACS Appl. Nano Mater 2020, 3, 6785–6797. [Google Scholar]
  • 132.Soni AK; Joshi R; Singh BP; Kumar NN; Ningthoujam RS Near-Infrared- and Magnetic-Field-Responsive NaYF4:Er3+/Yb3+@SiO2@AuNP@Fe3O4 Nanocomposites for Hyperthermia Applications Induced by Fluorescence Resonance Energy Transfer and Surface Plasmon Absorption. ACS Appl. Nano Mater 2019, 2, 7350–7361. [Google Scholar]
  • 133.Soni AK; Yadav KK; Singh BP; Joshi R; Chakraborty S; Chakravarty R; Nagaraja NK; Singh DK; Kain V; Dash A; et al. Smart YPO4:Er–Yb Nanophosphor for Optical Heating, Hyperthermia, Security Ink, Cancer Endoradiotherapy, and Uranyl Recovery. ACS Appl. Nano Mater 2021, 4, 850–860. [Google Scholar]
  • 134.Hsing I-M; Xu Y; Zhao W Micro- and Nano- Magnetic Particles for Applications in Biosensing. Electroanalysis 2007, 19, 755–768. [Google Scholar]
  • 135.Gu W; Deng X; Gu X; Jia X; Lou B; Zhang X; Li J; Wang E Stabilized, Superparamagnetic Functionalized Graphene/Fe3O4@Au Nanocomposites for a Magnetically-Controlled Solid-State Electrochemiluminescence Biosensing Application. Anal. Chem 2015, 87, 1876–1881. [DOI] [PubMed] [Google Scholar]
  • 136.Wu S; Wang H; Tao S; Wang C; Zhang L; Liu Z; Meng C Magnetic Loading of Tyrosinase-Fe3O4/Mesoporous Silica Core/Shell Microspheres for High Sensitive Electrochemical Biosensing. Anal. Chim. Acta 2011, 686, 81–86. [DOI] [PubMed] [Google Scholar]
  • 137.Dau TNN; Vu VH; Cao TT; Nguyen VC; Ly CT; Tran DL; Pham TTN; Loc NT; Piro B; Vu TT In-Situ Electrochemically Deposited Fe3O4 Nanoparticles onto Graphene Nanosheets as Amperometric Amplifier for Electrochemical Biosensing Applications. Sens. Actuators B Chem 2019, 283, 52–60. [Google Scholar]
  • 138.Chen F; Wu Q; Song D; Wang X; Ma P; Sun Y Fe3O4@PDA Immune Probe-Based Signal Amplification in Surface Plasmon Resonance (SPR) Biosensing of Human Cardiac Troponin I. Colloids Surf. B 2019, 177, 105–111. [DOI] [PubMed] [Google Scholar]
  • 139.Kim S-E; Tieu MV; Hwang SY; Lee M-H Magnetic Particles: Their Applications from Sample Preparations to Biosensing Platforms. Micromachines 2020, 11, 302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 140.Zhang Z; Kong J Novel Magnetic Fe3O4@C Nanoparticles as Adsorbents for Removal of Organic Dyes from Aqueous Solution. J. Hazard. Mater 2011, 193, 325–329. [DOI] [PubMed] [Google Scholar]
  • 141.Zhang H; Wu J-R; Wang X; Li X-S; Wu M-X; Liang F; Yang Y-W One-Pot Solvothermal Synthesis of Carboxylatopillar[5] Arene-Modified Fe3O4 Magnetic Nanoparticles for Ultrafast Separation of Cationic Dyes. Dyes Pigments 2019, 162, 512–516. [Google Scholar]
  • 142.Khalaf MM; Al-Amer K; Abd El-lateef HM Magnetic Fe3O4 Nanocubes Coated by SiO2 and TiO2 Layers as Nanocomposites for Cr (VI) up Taking from Wastewater. Ceram. Int 2019, 45, 23548–23560. [Google Scholar]
  • 143.Ren L; Lin H; Meng F; Zhang F One-Step Solvothermal Synthesis of Fe3O4@Carbon Composites and Their Application in Removing of Cr (VI) and Congo Red. Ceram. Int 2019, 45, 9646–9652. [Google Scholar]
  • 144.Behbahani ES; Dashtian K; Ghaedi M Fe3O4-FeMoS4: Promise Magnetite LDH-Based Adsorbent for Simultaneous Removal of Pb (II), Cd (II), and Cu (II) Heavy Metal Ions. J. Hazard. Mater 2021, 410, 124560. [DOI] [PubMed] [Google Scholar]
  • 145.Xin X; Wei Q; Yang J; Yan L; Feng R; Chen G; Du B; Li H Highly Efficient Removal of Heavy Metal Ions by Amine-Functionalized Mesoporous Fe3O4 Nanoparticles. Chem. Eng. J 2012, 184, 132–140. [Google Scholar]
  • 146.Fan H; Ma X; Zhou S; Huang J; Liu Y; Liu Y Highly Efficient Removal of Heavy Metal Ions by Carboxymethyl Cellulose-Immobilized Fe3O4 Nanoparticles Prepared via High-Gravity Technology. Carbohydr. Polym 2019, 213, 39–49. [DOI] [PubMed] [Google Scholar]
  • 147.Ansari A; Vahedi S; Tavakoli O; Khoobi M; Faramarzi MA Novel Fe3O4/Hydroxyapatite/β-Cyclodextrin Nanocomposite Adsorbent: Synthesis and Application in Heavy Metal Removal from Aqueous Solution. Appl. Organomet. Chem 2019, 33, e4634. [Google Scholar]
  • 148.Zhang F; Lan J; Zhao Z; Yang Y; Tan R; Song W Removal of Heavy Metal Ions from Aqueous Solution Using Fe3O4–SiO2-Poly(1,2-Diaminobenzene) Core–Shell Sub-Micron Particles. J. Colloid Interface Sci 2012, 387, 205–212. [DOI] [PubMed] [Google Scholar]
  • 149.Falahian Z; Torki F; Faghihian H Synthesis and Application of Polypyrrole/Fe3O4 Nanosize Magnetic Adsorbent for Efficient Separation of Hg2+ from Aqueous Solution. Glob. Chall 2018, 2, 1700078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 150.Hu H; Wang Z; Pan L Synthesis of Monodisperse Fe3O4@silica Core–Shell Microspheres and Their Application for Removal of Heavy Metal Ions from Water. J. Alloys Compd 2010, 492, 656–661. [Google Scholar]
  • 151.Wang N; Zhu L; Wang D; Wang M; Lin Z; Tang H Sono-Assisted Preparation of Highly-Efficient Peroxidase-like Fe3O4 Magnetic Nanoparticles for Catalytic Removal of Organic Pollutants with H2O2. Ultrason. Sonochem 2010, 17, 526–533. [DOI] [PubMed] [Google Scholar]
  • 152.Chen D; Shen Y; Wang S; Chen X; Cao X; Wang Z; Li Y Efficient Removal of Various Coexisting Organic Pollutants in Water Based on β-Cyclodextrin Polymer Modified Flower-like Fe3O4 Particles. J. Colloid Interface Sci 2021, 589, 217–228. [DOI] [PubMed] [Google Scholar]
  • 153.Zhu L; Li C; Wang J; Zhang H; Zhang J; Shen Y; Li C; Wang C; Xie A A Simple Method to Synthesize Modified Fe3O4 for the Removal of Organic Pollutants on Water Surface. Appl. Surf. Sci 2012, 258, 6326–6330. [Google Scholar]
  • 154.Villa S; Caratto V; Locardi F; Alberti S; Sturini M; Speltini A; Maraschi F; Canepa F; Ferretti M Enhancement of TiO2 NPs Activity by Fe3O4 Nano-Seeds for Removal of Organic Pollutants in Water. Materials 2016, 9, 771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 155.Sinan N; Unur E Fe3O4/Carbon Nanocomposite: Investigation of Capacitive & Magnetic Properties for Supercapacitor Applications. Mater. Chem. Phys 2016, 183, 571–579. [Google Scholar]
  • 156.Kumar R; Singh RK; Vaz AR; Savu R; Moshkalev SA Self-Assembled and One-Step Synthesis of Interconnected 3D Network of Fe3O4/Reduced Graphene Oxide Nanosheets Hybrid for High-Performance Supercapacitor Electrode. ACS Appl. Mater. Interfaces 2017, 9, 8880–8890. [DOI] [PubMed] [Google Scholar]
  • 157.Fan H; Niu R; Duan J; Liu W; Shen W Fe3O4@Carbon Nanosheets for All-Solid-State Supercapacitor Electrodes. ACS Appl. Mater. Interfaces 2016, 8, 19475–19483. [DOI] [PubMed] [Google Scholar]
  • 158.Sheng S; Liu W; Zhu K; Cheng K; Ye K; Wang G; Cao D; Yan J Fe3O4 Nanospheres in Situ Decorated Graphene as High-Performance Anode for Asymmetric Supercapacitor with Impressive Energy Density. J. Colloid Interface Sci 2019, 536, 235–244. [DOI] [PubMed] [Google Scholar]
  • 159.Zhou J; Zhang C; Niu T; Huang R; Li S; Zhang JZ; Chen JG Controlled Synthesis of Fe3O4 Nanospheres Coated with Nitrogen-Doped Carbon for High Performance Supercapacitors. ACS Appl. Energy Mater 2018, 1, 4599–4605. [Google Scholar]
  • 160.Zhou L; Fu Q; Xue F; Tang X; Zhou D; Tian Y; Wang G; Wang C; Gou H; Xu L Multiple Interfacial Fe3O4@BaTiO3/P(VDF-HFP) Core–Shell–Matrix Films with Internal Barrier Layer Capacitor (IBLC) Effects and High Energy Storage Density. ACS Appl. Mater. Interfaces 2017, 9, 40792–40800. [DOI] [PubMed] [Google Scholar]
  • 161.Li L; Wei S; Hu X; Su R; Zhang D; Wang Z; Yang Y Construction of Ternary Core-Shell Fe3O4@BaTiO3/PVDF Nanocomposites with Enhanced Permittivity and Breakdown Strength for Energy Storage. Mater. Chem. Phys 2021, 265, 124505. [Google Scholar]
  • 162.Chen JS; Zhang Y; Lou XW (David) One-Pot Synthesis of Uniform Fe3O4 Nanospheres with Carbon Matrix Support for Improved Lithium Storage Capabilities. ACS Appl. Mater. Interfaces 2011, 3, 3276–3279. [DOI] [PubMed] [Google Scholar]
  • 163.Komaba S; Mikumo T; Yabuuchi N; Ogata A; Yoshida H; Yamada Y Electrochemical Insertion of Li and Na Ions into Nanocrystalline Fe3O4 and A-Fe2O3 for Rechargeable Batteries. J. Electrochem. Soc 2009, 157, A60. [Google Scholar]
  • 164.Behera SK Enhanced Rate Performance and Cyclic Stability of Fe3O4 –Graphene Nanocomposites for Li Ion Battery Anodes. Chem. Commun 2011, 47, 10371–10373. [DOI] [PubMed] [Google Scholar]
  • 165.Zhu S; Marschilok AC; Takeuchi ES; Yee GT; Wang G; Takeuchi KJ Nanocrystalline Magnetite: Synthetic Crystallite Size Control and Resulting Magnetic and Electrochemical Properties. J. Electrochem. Soc 2010, 157, A1158. [Google Scholar]
  • 166.Chen Y-J; Xiao G; Wang T-S; Ouyang Q-Y; Qi L-H; Ma Y; Gao P; Zhu C-L; Cao M-S; Jin H-B Porous Fe3O4/Carbon Core/Shell Nanorods: Synthesis and Electromagnetic Properties. J. Phys. Chem. C 2011, 115, 13603–13608. [Google Scholar]
  • 167.Su J; Cao M; Ren L; Hu C Fe3O4–Graphene Nanocomposites with Improved Lithium Storage and Magnetism Properties. J. Phys. Chem. C 2011, 115, 14469–14477. [Google Scholar]
  • 168.Zhou G; Wang D-W; Li F; Zhang L; Li N; Wu Z-S; Wen L; Lu GQ; Cheng H-M Graphene-Wrapped Fe3O4 Anode Material with Improved Reversible Capacity and Cyclic Stability for Lithium Ion Batteries. Chem. Mater 2010, 22, 5306–5313. [Google Scholar]
  • 169.Ban C; Wu Z; Gillaspie DT; Chen L; Yan Y; Blackburn JL; Dillon AC Nanostructured Fe3O4/SWNT Electrode: Binder-Free and High-Rate Li-Ion Anode. Adv. Mater 2010, 22, E145–E149. [DOI] [PubMed] [Google Scholar]
  • 170.Ma Y; Zhang C; Ji G; Lee JY Nitrogen-Doped Carbon-Encapsulation of Fe3O4 for Increased Reversibility in Li+ Storage by the Conversion Reaction. J. Mater. Chem 2012, 22, 7845–7850. [Google Scholar]
  • 171.Wei W; Yang S; Zhou H; Lieberwirth I; Feng X; Müllen K 3D Graphene Foams Cross-Linked with Pre-Encapsulated Fe3O4 Nanospheres for Enhanced Lithium Storage. Adv. Mater 2013, 25, 2909–2914. [DOI] [PubMed] [Google Scholar]

RESOURCES